Management of medication preparation with formulary management

ABSTRACT

A pharmacy workflow management application with improved functionality related thereto. The improved functionality may include enhancements to a user interface for maintenance of a formulary at a local system executing the pharmacy workflow management application. The formulary management may include user interface elements provided at least partially based on a user profile. Additional enhancements to a user interface associated with a user profile may be provided for dose order record maintenance using the pharmacy workflow management application. Furthermore, enhancements to triggered scan events for updating a status of a dose order, situation board enhancements related to formatting of the situation board in relation to a user profile, encryption of communication by the pharmacy workflow application, and improved methods of installing updates to terminals of the pharmacy workflow management application are discussed.

CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority from U.S. Provisional Application No.62/057,906 filed on Sep. 30, 2014, entitled “MANAGEMENT OF MEDICATIONPREPARATION WITH FORMULARY MANAGEMENT,” the contents of which areincorporated by reference herein as if set forth in full.

BACKGROUND

In many medical facilities, medication orders are provided to a pharmacyfor preparation of doses corresponding to the medication orders foradministration to a patient. In this regard, orders must be entered,received by the pharmacy, validated, and prepared according tomanufacturer's specifications or established institutional guidelines.The preparation process involves the selection and, where required,preparation of drug products for administration to patients incompliance with the validated order. Once filled, the resulting drugproducts (i.e., doses) must be delivered to the patient that requiresthem. One environment, by way of example, in which such processes occuris a hospital.

There are points in the foregoing process that may be susceptible to theloss or corruption of information due to miscommunication or othererrors. This can be problematic in terms of logging and auditing ofmedication doses, which may be required by insurance and regulatoryrequirements. In turn, systems for management of pharmacy work flow havebeen proposed. For example, U.S. Provisional Patent Application No.61/975,519 entitled “MANAGEMENT OF MEDICATION DOSE ORDERS” filed on Apr.4, 2014, which is co-owned with the present application and incorporatedby reference herein in the entirety, discloses certain embodiments of apharmacy workflow management application. Accordingly, at leastpartially automated pharmacy workflow management applications have beendevised to assist in management of the receipt, processing,organization, preparation, verification, and tracking of medication doseorders in the pharmacy or the like. However, further developments wouldbe beneficial to assist in improvements to the pharmacy workflowmanagement application to promote efficiency, reliability, and accuracyrelated to the preparation and management of medication dose orders.

SUMMARY

In view of the foregoing, the present disclosure is generally related tovarious embodiments of pharmacy workflow management applications. Incertain embodiments of the pharmacy workflow management applicationdescribed herein, improvements in the management of a formulary arepresented. Additionally, the present disclosure includes embodimentsthat relate to improvements in user interface elements of a pharmacyworkspace management tool. Further still, enhancements to the trackingof dose orders using the pharmacy workflow management application arealso discussed. Further still, enhancements to a situation board forhigh-level overview displays in relation to current pharmacy work loadand other pharmacy activities are discussed. Additionally, improvementswith respect to secure communications at a facility and improvements inrelation to workstation application updates are also discussed. Furtherstill, improvements to the local installation of an updated softwarefree from administrator-level credentials are also discussed.

The present disclosure generally includes discussion related to theconfiguration of a user interface in relation to a user profile in orderto provide for a customized display of one or more records to a userwith which the user profile is associated. In this regard, the user mayprovide user authentication information. This user authenticationinformation may be particular to a given user. In turn, upon receipt ofthe user authentication information, the application may associate auser profile with a given user accessing the application. Various userinterface elements presented to the user may be customized based uponthe associated user profile. In particular, the user profile may allowfor default configurations of user interface elements and/orconfiguration of user interface elements according to the last accessedconfiguration which is stored with user profile.

In this regard, a customized user interface associated with the userprofile may be used to display records to a user. As may be appreciated,the records displayed to the user using the user interface may beretrieved from a database at the system executing the pharmacy workflowmanagement application. In turn, the database records may relate to anumber of various types of records maintained at the local system. Inone specific example, the records may be formulary records related to aformulary database maintained at the local system at which the pharmacyworkflow management application executes. In yet another specificexample, the records may correspond to dose order records stored at thelocal system at which the pharmacy workflow management applicationexecutes. In either regard, upon display of the records to the user, thedisplay may at least partially be based on the user profile of the useraccessing the records.

In connection with the foregoing, the formulary may comprise a pluralityof records stored in a database. In this regard, the formulary recordsmay be related to (e.g., categorized according to) administrationroutes, drug categories, drugs, materials, product groups, and/orproducts that may be utilized by the pharmacy in the preparation ofdoses. The formulary records may be used during the preparation processby a pharmacy technician and/or the pharmacy workflow managementapplication to assist in the preparation of a dose, the management ofdose order records, or other activities related to the pharmacy workflowmanagement application.

In additional embodiments described herein, improvements in relation toa pharmacy workspace queue for use in a pharmacy workflow managementapplication are also discussed. The present disclosure also includesvarious aspects to facilitate administration of the pharmacy workflow,including tracking dose order status through triggered scan events,monitoring pending dose orders on a customizable situation board,encrypting web traffic associated with the workflow, and facilitatingthe local installation of updated software versions free fromadministrator-level credentials.

In this regard, a first aspect of the present disclosure includes amethod for formulary management in a pharmacy workflow managementapplication. The method includes receiving, at a processor that executesthe pharmacy workflow management application, user authenticationinformation corresponding to a given user of the system. The methodfurther includes associating, by the processor, the user authenticationinformation with a user profile for the given user. The method furtherincludes accessing a plurality of formulary data records stored in adatabase accessible by the processor in response to a request for theplurality of formulary data records by the given user. The methodfurther includes displaying, using the processor, the plurality offormulary data records to the given user at a user interface, whereinthe user interface is configured at least partially based on the userprofile for the given user.

A number of feature refinements and additional features are applicableto the first aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the firstaspect.

For example, in an embodiment, the user interface may include aplurality of pages. Each of the plurality of pages may be associatedwith a formulary management function. A search area may be provided thatis operable to receive a user input. The user interface may also includea data table corresponding to the plurality of formulary data records.The method may further include identifying, by the processor,associations between the user input of the search area and the pluralityof formulary data records of the data table. The method may furtherinclude displaying, at the user interface, a filtered table result atleast partially based on the associations.

Moreover, the formulary data records may belong to at least one of aclass of formulary data records, such that the class of formulary datarecords is selected from the group consisting of: administration routes,drug categories, drugs, materials, product groups, and products. Assuch, the foregoing formulary management function may be selected fromthe group consisting of: management of administration routes, managementof drug categories, management of drugs, management of materials,management of product groups, and management of products. In this regarddifferent categories of formulary records may be managed. For instance,the management functions provided may depend upon the category offormulary record displayed.

In an embodiment, the user interface may also include a plurality ofmaintenance operations buttons displayable within each of the pluralityof pages such that the plurality of maintenance operations buttonsremains visible while each of the plurality of pages is scrolled. Themanagement buttons presented may depend upon the type of formularyrecord displayed. In this regard, the user interface presented to theuser may facilitate efficient management of different types of formularyrecords belonging to different corresponding categories.

In an embodiment, the plurality of pages may also include a plurality ofcollapsible areas configured to hide information when collapsed.Notably, the configuration of the plurality of collapsible areas may beassociated with the user profile. The collapsible area may include dataattributes of the formulary data records (e.g., the data attributes of aselected one of the formulary records) such that the data attributes ofthe formulary data records are modifiable in the collapsible area. Uponassociating the user authentication information with a user profile thegiven user, the plurality of collapsible areas may be arranged inaccordance with the user profile during the displaying. Moreover, eachof the plurality of collapsible areas may include a help icon,accessible by the user and operable to display context-specific helpinformation associated with the data attributes of the formulary recordof each of the plurality of collapsible areas.

In an embodiment, the plurality of formulary data records may beassociable with a data table of the user interface. Consequently, themethod may include modifying the data table of the user interface. Themethod may also include associating the modified data table with theuser profile. The method may also include presenting the modified datatable to the user during a subsequent user interface session. During theforegoing modification of the data table the quantity of data attributesdisplay in the data table may be changed or otherwise altered.Furthermore, the plurality of data attributes may be displayable indistinct columns of the data table. As such, during the data tablemodification the width of the distinct columns of the data table may beresized.

The at least one of the plurality of formulary data records may alsoinclude at least one data attribute defined by one or more selectedvalues from a list comprising a plurality of values. Each of theplurality of values may be alterable within the list without deletingthe value or adding a new value. The list may also include a query boxoperable to receive a user input. From this user input, the processormay identify, from the plurality of values, associations between theuser input of the query box and the plurality of values of the list anddisplay a filtered list result at least partially based on theidentified associations.

In an embodiment, the displaying may include displaying the numericalvalues of the plurality of formulary data records according to Institutefor Safe Medical Practice (ISMP) standard format. As such, the methodmay include modifying a given user input to conform to the ISMP standardformat. In this regard, uniformity may be achieved such that errorsbased on misread, misunderstood, or incorrectly transcribed values.

Furthermore, in an embodiment of the formulary management in a pharmacyworkflow management application, each of the plurality of formulary datarecords may comprise a plurality of characteristics of existingformulary data. In this regard, the method may include modifying atleast one of the characteristics of at least one of the plurality offormulary data records, at the user interface, without deleting the atleast one of the plurality of formulary data records or adding a newformulary data record to the plurality of formulary data records. Themethod may also include presenting the modified at least one of theplurality of formulary data records to the user during a subsequentsession.

A second aspect includes a method for managing a pharmacy workspacequeue in a pharmacy workflow management application. The method includesreceiving, at a processor that executes the pharmacy workflow managementapplication, user authentication information corresponding to a givenuser of the system. The method further includes associating, by theprocessor, the user authentication information with a user profile forthe given user. The method further includes accessing a plurality ofdose order records corresponding to dose orders received by the pharmacyworkflow management application in response to a request for theplurality of dose order records by the given user. The method furtherincludes displaying the plurality of dose order records to the givenuser at a user interface of the pharmacy workflow managementapplication. Accordingly, the user interface is configured at leastpartially based on the user profile for the given user.

A number of feature refinements and additional features are applicableto the second aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the secondaspect.

For example, in an embodiment, the plurality of dose order records mayinclude at least a first dose order record corresponding to a first doseorder that has not been prepared and at least a second dose order recordcorresponding to a second dose order that has been prepared and has notyet been verified by a pharmacist. Furthermore, the user interface mayinclude a plurality of pages such that each of the plurality of pages isassociated with a pharmacist workspace queue management function. Thepharmacist workspace queue management function may be selected from thegroup of management functions, which consist of: managing dose order onwait/hold status, managing dose order on inline dose, managing doseorder on STAT dose, managing dose order on final/STAT dose, and managingdose order being verified.

In an embodiment, the user interface may include a plurality ofcollapsible areas such that the collapsible areas include a plurality ofdata attributes of at least one of the plurality of dose order recordsand are associated with at least one of plurality of informationalgroups. The data attributes may be arranged with at least one of theplurality of collapsible areas at least partially based on anassociation between the data attributes and at least one of theplurality of informational groups. Furthermore, the plurality ofinformational groups may be selected from the group consisting of: doseinformation, patient information, clinical information, formularyinformation, and documentation information. Notably, the collapsibleareas may be configured to hide information when collapsed, and theconfiguration of the plurality of collapsible areas may be associatedwith the user profile. Accordingly, the plurality of collapsible areasmay be arranged in accordance with the user profile, such that thearranged configuration is displayed in the method.

In an embodiment, the pharmacy workflow management application includesvarious features pertaining the standard presentation of data, such asthe plurality of dose order records. In this regard, the plurality ofdose order records may be configured according to ISMP standard format.Furthermore, the method may include displaying a print view of at leastone of the plurality of dose order records. In this regard, the printview may include detailed dose information and product information.

In an embodiment, the method may further comprise modifying at least oneof the plurality of dose order records at the user interface.Specifically, an external document may be dragged to the user interface(e.g., to a document input page of the user interface) such that theexternal document is associated with at least one of the plurality ofdose order records. The plurality of dose order records may include aplurality of external document attachments such that the displayingincludes displaying the external document attachments for at least oneof the plurality of dose order records. The attached document maycomprise a number of file types such as word processing documents,spreadsheet documents, image files, portable document format (PDF)files, or the like.

In another embodiment, the plurality of dose order records may beassociable with a data table of the user interface such that theplurality of dose order records includes a plurality of characteristics.In this regard, the method may also include modifying at least one ofthe plurality of characteristics of at least one of the dose orderrecords. Furthermore, the data table may be configurable to display, foreach of the plurality of dose order records, at least one of dosehistory, product history, or scan event data. Accordingly, each of theplurality of dose order records may be stored in corresponding relationto one or more dose order record data fields populated with dose ordermetadata regarding each dose order record. The at least one dose orderrecord data field may correspond to a dose order status indication ofthe at least one dose order record in relation to a dose preparationstep of the at least one dose order record such that the scan event datais at least partially based on the dose order status metadata.

A third aspect includes a method for management of dose order records.The method may include storing a plurality of dose order records in adatabase of a dose order management server such that each dose orderrecord is stored in corresponding relation to one or more dose orderrecord data fields populated with dose order metadata regarding eachdose order record. Furthermore, the at least one dose order record datafield for a given dose order record may correspond to a dose orderstatus indicative of a status of the given dose order record relative toa particular dose preparation step in a dose preparation protocol forthe at least one dose order record. The method further includesidentifying a first dose order record. The method further includesmodifying the dose order status for the given dose order from a firstvalue to a second value at least partially in response to an inputreceived from a user in connection with the dose preparation step.Notably, the dose preparation step is associated with an independentpharmacy workflow of the dose preparation protocol to prepare a dosecorresponding to the at least one dose order record.

A number of feature refinements and additional features are applicableto the third aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the thirdaspect.

For example, in an embodiment, the independent pharmacy workflowoperation may relate to preparation of a dose corresponding to the givendose order record free from modifying the dose order status value. Thesecond dose order status may include a plurality of values associatedwith various indications of dose order status.

By way of illustration, numerous examples of the plurality of value ofthe second dose order status are described. For instance, the seconddose order status value may include a preparation cancelled status suchthat the preparation cancelled status indicates the one or more doseorders of the first dose order record is, after being selected forpreparation, returned to a queue of dose order records to be prepared.The second dose order status value may include a dose removed fromwait/hold status such that the dose removed from wait/hold statusindicates the one or more dose orders of the first dose order record ismoved from a wait/hold queue. The second dose order status value mayinclude a dose at inline verification status such that the dose atinline verification status indicates the one or more dose orders of thefirst dose order record is transmitted for remote inline verification inmanner where the user input relates to scanning an intermediate productused in the preparation of the dose. The second dose order status valuemay include a dose reused status such that the dose reused statusindicates the dose of the given dose order record is reused in anotherof the one or more dose orders in a manner where the user input includesan association of the dose to the another of one or more dose orders.

By way of continued illustration, the second dose order status value mayinclude a dose kitted status such that the dose kitted status indicatesthe one or more dose orders of the first dose order record is added to akit in a manner where the user input includes a scan to associate thedose corresponding to the given kit. The second dose order status valuemay include a dose at compounder status such that the dose at compounderstatus indicates the one or more dose orders of the first dose orderrecord is printed for compounding. The second dose order status valuemay include a dose bypassed status such that the dose bypassed statusindicates the one or more dose orders of the first dose order record isprinted for preparation outside of the system. The second dose orderstatus value may include a dose prep started status such that the doseprep started status indicates one or more dose orders of the first doseorder record has begun a dose preparation process. In this regard, thestatus change may be accomplished in manner in which the user inputincludes a scan of a label corresponding to the given dose order toretrieve a dose preparation protocol for the given dose order record.

By way of additional illustration, the second dose order status valuemay include a dose sent for rework status such that the dose sent forrework status indicates one or more dose orders of the first dose orderrecord is returned to a dose order queue for rework. The second doseorder status value may include a dose lost status such that the doselost status indicates the one or more dose orders of the dose orderrecord is lost. The second dose order status value may include a doserejected status such that the dose rejected status indicates the one ormore dose orders of the dose order record is rejected. The second doseorder status value may include a dose added to wait/hold status suchthat the dose added to wait/hold status indicates one or more doseorders of the dose order record is added to a wait/hold queue. Thesecond dose order status value may include a dose removed from kitstatus such that the dose removed from kit status indicates one or moredose orders of the dose order record is removed from a kit. This may beaccomplished in a manner where the user input includes a scan confirmingreceipt of the kit. The second dose order status value may include adose discontinued status such that the dose discontinued statusindicates one or more dose orders of the dose order is discontinued.

Furthermore, in an embodiment, the plurality of dose order records maybe associable with a data table of the user interface such that the datatable is configurable to display the scan event of the given dose orderrecord. Further still, the first and/or second status associated with ascan event may be established using the user interface. In this regard,the nature of the scan even (e.g., the trigger of a change in status,the status from which the order is changed, and the status to which theorder is changed) may be configured by a user.

A fourth aspect includes a method for use in communicating informationpertaining to a pharmacy workspace queue in a pharmacy workflowmanagement application. The method includes receiving, at a processorexecuting the pharmacy workflow management application, userauthentication information corresponding to a given user of the system.The method further includes associating, by the processor, the userauthentication information with a user profile for the given user. Themethod further includes accessing a plurality of dose order recordscorresponding to dose orders received at the pharmacy workflowmanagement application in response to a request for the plurality ofdose order records by the given user. The method also includesdisplaying the plurality of dose order records to the given user at auser interface of the server such that the first dose order record andthe second dose order record each appear in at least one distinct moduleof a common dashboard. The dashboard may include a plurality of themodules and be configurable to communicate the status of at least one ofthe plurality of dose orders in the pharmacy workspace queue to a usersuch that the configuration is at least partially based on the userprofile for the given user.

A number of feature refinements and additional features are applicableto the fourth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the fourthaspect.

For example, in an embodiment, the plurality of dose order records mayinclude at least a first dose order record corresponding to a first doseorder that has not been prepared and at least a second dose order recordcorresponding to second dose order that has been prepared and has notyet be verified by a pharmacist. Moreover, the configuration of theforegoing dashboard may be at least partially based on a cascading stylesheet declaration contained within a single file.

Furthermore, in an embodiment, the configuration of the modules may beassociated with a module profile, such that the user profile may beassociated with a module profile. In this regard, the plurality ofmodules may be displayed in accordance with the module profile.Additionally, the module profile may include alphanumericalcustomization preferences such that the alphanumerical customizationpreferences include at least a color preference, a font preference, asize preference, or a text effects preference.

In an embodiment, the method may further include sorting the pluralityof dose orders of the at least one module at least partially based on asorting criterion. The sorting criterion may include, for example, atleast one of a dose priority, a patient name, an expiration data, or anexpiration time. The sorting of the method may also include sorting theplurality of dose orders of the at least one module at least partiallybased on sorting criteria in ascending or descending order.

In a further embodiment, each of the plurality of dose order records maybe associated with a durational indicator that indicates the length oftime elapsed since a milestone event. In this regard, a milestone eventmay represent a change of status of at least one of the plurality ofdose order records. Accordingly, the change of status corresponds toidentifying modified dose order metadata regarding at least one of theplurality of dose order records such that the modified dose ordermetadata is modified with respect to corresponding portions of doseorder metadata at least partially obtained in response to an inputreceived from the user.

A fifth aspect includes a method for secure local network access of apharmacy workflow management application. The method includesestablishing an operative communication link between a terminal and thepharmacy workflow management application that stores a plurality of doseorder records corresponding to dose orders received at the pharmacyworkflow management application. The terminal may be disposed within atleast one network of a local area network. The method further includescryptographically manipulating data routed through the operativecommunication link such that the operative communication link provides asecure data connection between the terminal and the server. The methodfurther includes accessing the server using the terminal to retrieve aplurality of dose order records from the pharmacy workflow managementapplication. The method further includes displaying the plurality ofdose order records to a user at the terminal.

A number of feature refinements and additional features are applicableto the fifth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the fifthaspect.

For example, in an embodiment, the plurality of dose order recordsinclude at least a first dose order record corresponding to a first doseorder that has not been prepared and at least a second dose order recordcorresponding to a second dose order that has been prepared and has notbeen verified by a pharmacist. The cryptographic manipulation of themethod may further include translating the data routed through theoperative communication link into an illegible format between theterminal and the pharmacy workflow management application. In thisregard, the secure connection is operable to prevent third partyinterference of the data routed through the operative communicationlink. Notably, for example, the interference may include eavesdroppingand tampering, which may at least in part be reduced using thecryptographic manipulation of the data communicated.

In other embodiments, the secure connection is provided via a securesocket layer cryptographic protocol. In this regard, the secure socketlayer cryptographic protocol may translate the data into a legibleformat at each of the terminal and the server at least partially basedon a signed digital certificate associated with an authenticated user.

A sixth aspect includes a method for use in upgrading a terminal of alocal network system for management of medication dose orders. Themethod includes storing a workstation version in a database of apharmacy workflow management application that stores a plurality of doseorder records corresponding to dose orders received at the pharmacyworkflow management application. The method further includes,identifying a workstation version of a terminal disposed within at leastone network of a common enterprise network. The method further includes,establishing an operative communication link between the terminal andthe pharmacy workflow management application. The method furtherincludes, comparing the workstation version of the terminal with theworkstation version stored in the database. The method further includes,determining whether the workstation version stored in the databasesupersedes the workstation version of the terminal. The method furtherincludes, presenting to a user an option to download the workstationversion stored in the database on to the terminal.

A number of feature refinements and additional features are applicableto the sixth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the sixthaspect.

For example, in an embodiment, the method may further includedownloading, in response to the user selected option, the workstationversion stored in the database on to the terminal. In this regard, theworkstation version stored in the database may be downloaded on to theterminal by the user. Notably, the user need not be an administrativeuser with credentials to upgrade the pharmacy workflow managementapplication. Additionally, the method may further include downloadingthe workstation version stored in the database on to the terminalwithout hardware drivers or crystal reports.

A seventh aspect includes a system for formulary management in apharmacy workflow management application. The system includes an accessterminal remote from and in operative communication with the pharmacyworkflow management application. The pharmacy workflow managementapplication may therefore be operable to access a plurality of formularydata records stored in a database of the pharmacy workflow managementapplication in response to a request for the plurality of formulary datarecords by a given user. The system further includes a user interfaceprovided at the access terminal for displaying the plurality offormulary data records stored in the database. Furthermore, the pharmacyworkflow management application may be operable to receive, at aprocessor of the pharmacy workflow management application, userauthentication information corresponding to the given user of thesystem. Consequently, the pharmacy workflow management application isoperable to associate, at the processor, the user authenticationinformation with a profile for the given user such that the userinterface is configured at least partially based on the user profile forthe given user.

A number of feature refinements and additional features are applicableto the seventh aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of theseventh aspect. For instance, any of the features discussed with any ofthe foregoing aspects, and in particular the first aspect, may be usedin conjunction with the seventh aspect without limitation.

An eight aspect includes a system for pharmacy workspace queuemanagement in a pharmacy workflow management application. The systemincludes an access terminal remote from and in operative communicationwith a pharmacy workflow management such that the pharmacy workflowmanagement may be operable to access a plurality of dose order recordscorresponding to dose orders received at the server in response to arequest for the plurality of dose order records by a given user. Thesystem further includes a user interface provided at the access terminalfor displaying the plurality of dose order records to the given user ata user interface of the server. Furthermore, the server is operable toreceive, at a processor of the pharmacy workflow management, userauthentication information corresponding to the given user of thesystem. Consequently, the pharmacy workflow management is operable toassociate, at the processor, the user authentication information with aprofile for the given user such that the user interface is configured atleast partially based on the user profile of the given user.

A number of feature refinements and additional features are applicableto the eighth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the eighthaspect. For instance, any of the features discussed with any of theforegoing aspects, and in particular the second aspect, may be used inconjunction with the seventh aspect without limitation.

A ninth aspect includes a system for the management of dose orderrecords. The system includes an access terminal remote from and inoperative communication with a dose management server. The dosemanagement server may be operable to store a plurality of dose orderrecords in a database of the dose order management server. Specifically,each dose order record is stored in corresponding relation to one ormore dose order record data fields populated with dose order metadataregarding each dose order record such that at least one dose orderrecord data field for a given dose order record corresponds to a doseorder status indicative of a status of the given dose order recordrelative to a particular dose preparation step in a dose preparationprotocol for the at least one dose order record. The system furtherincludes a user interface provided at the remote access terminal.Furthermore, the dose management server may be operable to identify afirst dose order record. Additionally, the dose management server mayalso be operable to modify the dose order status for the given orderfrom a first value to a second value at least partially in response toan input received from a user in connection with the dose preparationstep such that the dose preparation step is associated with anindependent pharmacy workflow of the dose preparation protocol toprepare a dose corresponding to the at least one dose order record.

A number of feature refinements and additional features are applicableto the ninth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the ninthaspect. For instance, any of the features discussed with any of theforegoing aspects, and in particular the third aspect, may be used inconjunction with the seventh aspect without limitation.

A tenth aspect includes, a system for use in communicating informationpertaining to a pharmacy workspace queue in a pharmacy workflowmanagement application. The system includes an access terminal remotefrom an in operative communication with a pharmacy workflow managementapplication. The pharmacy workflow management application may beoperable to access a plurality of dose order records corresponding todose orders received at the server in response to a request for theplurality of dose order records by a given user. The system furtherincludes a user interface provided at the remote access terminal fordisplaying the plurality of dose order records to the given user at theuser interface such that the first dose order record and the second doseorder record each appear in at least one distinct module of a commondashboard. Furthermore, the dashboard may include a plurality of themodules, which are configurable to communicate the status of at leastone of the plurality of dose orders in the pharmacy workspace queue tothe user such that the configuration is at least partially based on theuser profile for the given user. Additionally, the server may beoperable to receive, at a processor of the pharmacy workflow managementapplication, user authentication information corresponding to the givenuser of the system such that the pharmacy workflow managementapplication may be operable to associate, at the processor, the userauthentication information with a profile for the given user.Accordingly, the user interface is configured at least partially basedon the user profile for the given user.

A number of feature refinements and additional features are applicableto the tenth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of the tenthaspect. For instance, any of the features discussed with any of theforegoing aspects, and in particular the fourth aspect, may be used inconjunction with the seventh aspect without limitation.

An eleventh aspect includes a system for securing local network accessof a pharmacy workflow management application. The system includes anaccess terminal remote from and in operative communication with apharmacy workflow management application, over an operativecommunication link. In particular, the pharmacy workflow managementapplication may be operable to store a plurality of dose order recordscorresponding to dose orders received at the pharmacy workflowmanagement application. The terminal may be disposed within at least onenetwork of a local areas network. The server may be operable tocryptographically manipulate data routed through the operativecommunication link such that the operative communication link provides asecure data connection between the terminal and the server. The systemfurther includes a user interface provided at the remote access terminalfor displaying the plurality of dose order records at the remote accessterminal.

A number of feature refinements and additional features are applicableto the eleventh aspect. These feature refinements and additionalfeatures may be used individually or in any combination. As such, eachof the following features that will be discussed may be, but are notrequired to be, used with any other feature combination of features ofthe eleventh aspect. For instance, any of the features discussed withany of the foregoing aspects, and in particular the fifth aspect, may beused in conjunction with the seventh aspect without limitation.

A twelfth aspect includes a system for use in upgrading a terminal of alocal network system for management of medication dose orders. Thesystem includes an access terminal remote from and in operativecommunication with a pharmacy workflow management application, over anoperative communication link. The pharmacy workflow managementapplication may be operable to store a workstation version in a databaseof the pharmacy workflow management application that stores a pluralityof dose order records corresponding to dose orders received at thepharmacy workflow management application. Moreover, the pharmacyworkflow management application may also be operable to identify aworkstation version of the remote access terminal, which may be disposedwithin at least one network of a common enterprise network. Notably, thepharmacy workflow management application may be operable to compare theworkstation version of the remote access terminal with the workstationversion stored in the database, such that the pharmacy workflowmanagement application is operable to determine whether the workstationversion stored in the database supersedes the workstation version of theremote access terminal. The system further includes a user interfaceprovided at the remote access terminal for presenting to a user anoption to download the workstation version stored in the database to theterminal.

A number of feature refinements and additional features are applicableto the twelfth aspect. These feature refinements and additional featuresmay be used individually or in any combination. As such, each of thefollowing features that will be discussed may be, but are not requiredto be, used with any other feature combination of features of thetwelfth aspect. For instance, any of the features discussed with any ofthe foregoing aspects, and in particular the sixth aspect, may be usedin conjunction with the seventh aspect without limitation.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic view of an embodiment of a system including apharmacy workflow management application executed at a local system.

FIG. 2 is a schematic view of an embodiment of a local system comprisinga pharmacy workflow management application.

FIG. 3 is a flow chart depicting an embodiment of a method for receiptand processing of dose orders.

FIG. 4 is a schematic view depicting various functionalities of thepharmacy workflow management application executed by the local systemshown in FIG. 2.

FIG. 5 is a view of an embodiment of a user interface of a pharmacyworkflow management application with which dose order records stored bythe pharmacy workflow management application may be managed.

FIGS. 6-12 are views of an embodiment of a user interface of a pharmacyworkflow management application that provides management of dose orderrecords stored by the pharmacy workflow management application.

FIG. 13 depicts a flow chart of an embodiment of a method for processingdose order records to prepare a corresponding dose at a workstation.

FIGS. 14-15 depict an embodiment of a user interface of a pharmacyworkflow management application presented to a user when preparing adose corresponding to a dose order record.

FIGS. 16-17 depict an embodiment of a user interface of the pharmacyworkflow management application that may be presented to a pharmacistwhen reviewing a dose.

FIGS. 18, 19A, 19B, and 20 depict an embodiment of a user interface of apharmacy workflow management application utilized by a pharmacist whenreviewing a dose.

FIG. 21 depicts a flow chart of an embodiment of a method for reviewdoses by a pharmacist.

FIGS. 22-34 depict an embodiment of a user interface for use informulary management.

FIGS. 35-46 depict an embodiment of a user interface for display of doseorder record detail information for a dose order record.

FIG. 47 depicts an embodiment of a situation board display that iscustomized according to a user profile.

FIG. 48 depicts an embodiment of a situation board display withcustomizable sorting options.

FIG. 49 depicts an embodiment of a plurality of scan events that arecustomizable with respect to modification of the dose status in relationto an independent pharmacy workflow operation in relation to preparationof a dose order record.

FIG. 50 depicts an embodiment of a user interface used to customize scanevents in relation to the operation of a scan event relative to a doseorder.

DETAILED DESCRIPTION

The following description is not intended to limit the invention to theforms disclosed herein. Consequently, variations and modificationscommensurate with the following teachings, skill and knowledge of therelevant art, are within the scope of the present invention. Theembodiments described herein are further intended to explain modes knownof practicing the invention and to enable others skilled in the art toutilize the invention in such, or other embodiments and with variousmodifications required by the particular applications(s) or use(s) ofthe present invention.

The present disclosure contemplates a pharmacy workflow managementapplication that may facilitate pharmacy workflow management in relationto preparation of one or more doses at a pharmacy, hospital, or otherfacility at which doses are prepared for administration to a patient.The pharmacy workflow management application may be executed at a localsystem (also referred to herein as a local node). The local node maycorrespond to a facility such as a hospital, pharmacy, or other facilitycapable of preparing a dose for administration to a patient. Pharmacyworkflow management provided by the pharmacy workflow managementapplication may include one or more activities within a pharmacy thatmay include management of a locally stored formulary, processingreceived medication dose orders at a pharmacy, creating correspondingdose order records for each received dose order, managing (e.g.,viewing, sorting, prioritizing, etc.) dose order records, guiding apharmacy technician in preparing the dose order medication, gatheringinformation regarding the preparation of a dose to fulfill a dose order,reviewing the medication dose order, and/or tracking of medication doseorder records in the pharmacy.

The local node may comprise one or more devices that may includehardware and/or software that may execute machine readable instructionsstored as machine readable non-transitory data in a memory. The machinereadable instructions, when executed by a processor may providefunctionality related to the pharmacy workflow management applicationdiscussed herein. In this regard, the pharmacy workflow managementapplication may include one or more processors operative to accessmachine-readable data stored in a storage medium (i.e., a memory) thatprovide instructions to the one or more processors for execution toprovide the functionality described herein.

The local node executing the pharmacy workflow management applicationmay be in operative communication with a central server. The centralserver may provide support services to the local node to support thepharmacy workflow management application and/or may provide additionalservices such as data backup, report generation, or access to data setsstored at the central server.

The present disclosure includes a description of an embodiment of doseorder processing that may be performed by the pharmacy workflowmanagement application. This dose order processing may include receivingdose orders and generating dose order records that are in turn stored bythe application. Also described herein are embodiments that providefunctionality related to the management of the dose order records withinthe pharmacy. The management functionality of the pharmacy workflowmanagement application may include, but is not limited to, viewing,sorting, modifying, prioritizing, organizing, or otherwise managing doseorder records. The pharmacy workflow management application may alsodistribute, provide, or assign dose order records to workstations forpreparation of a dose (i.e., a physical dose form capable of beingadministered to a patient) that corresponds to a dose order record. Thepharmacy workflow management application may provide a protocol inrelation to a dose order record to assist a user in preparing a doseassociated with a dose order record. During the preparation, dose ordermetadata regarding the dose prepared in connection with the dose orderrecord may be recorded or acquired. In connection with the preparationof the dose, embodiments of functionality related to remote pharmacyverification are also described. Furthermore, features related to theability to utilize the application to track dose orders in the pharmacy(e.g., with respect to physical location and/or processing status in orother relevant status indications) are described.

With initial reference to FIG. 1, a system 100 is depicted that includesa plurality of local systems 110. The local systems 110 may eachcomprise a local node in the system 100. The local systems 110 may eachexecute a pharmacy workflow management application 114. For instance,each local system 110 may include at least one local device executing aclient application for providing functions related to the pharmacyworkflow management application. As shown in FIG. 1, a plurality oflocal systems 110 may be provided that are each in operativecommunication with a central server 120. For example, the local systems110 may be in operative communication the central server 120 by way of awide area network 50 (e.g., the Internet).

Each local system 110 may be a healthcare facility such as a hospital,pharmacy, outpatient clinic, or the like, that prepares doses foradministration to a patient. The respective pharmacy workflow managementapplication 114 at each local system 110 may be operative to generateand/or capture medical information that may be provided to the centralserver 120 by way of the wide area network 50. As will come to beappreciated from the discussion below in relation to the pharmacyworkflow management application 114, the medical information may includemedication dose order data that may include metadata regarding the doseorder record and/or dose. The pharmacy workflow management application114 each local system 110 may allow for the pharmacy workflow managementfunctions described in greater detail below. In any regard, any or alldata generated by the pharmacy workflow management application may beprovided to the central server 120. In this regard, central server 120may provide for data collection and/or data backup services in relationto the local systems 110 as well as other functions described in greaterdetail below.

Accordingly, in at least one embodiment the local systems 110 maycomprise unaffiliated and discrete healthcare facilities capable ofpreparing medication doses for administration to patients. The centralserver 120 may be hosted by another discrete and unaffiliatedthird-party that may be separate from any of entities of the localsystems 110. For instance, the central server 120 may be hosted and/orexecuted by an application provider that provides one or more clientapplications for execution by the local systems 110 to facilitate thepharmacy workflow management application 114. Specifically, the centralserver 120 may be executed or hosted by an application provider thatprovides the pharmacy workflow management application each local system110.

The central server 120 may provide, among other resources, a centraloperations portal 122, a management report portal 124, and/or a datawarehouse portal 126. Generally, the central operations portal 122 mayprovide, among other resources, data backup services to the pharmacyworkflow management application 114 of each local system 110. Themanagement report portal 124 may allow a user accessing this resource togenerate management reports that may relate to collectives of localsystems 110 or individual local systems 110. For example, one or morelocal systems 110 may belong to an organization such that the datacorresponding to the collective local systems 110 comprising theorganization may be aggregated (e.g., at the central server 120). Inthis regard, organizational users may be defined that are members oflocal systems 110 belonging to an organization such that theorganizational users may be able to access data related to any of thelocal systems 110 belonging to the organization. The management reportsmay include data in relation to the medical information received fromone or more local systems 110.

Furthermore, a data warehouse portal 126 may be provided that mayprovide an aggregated source of medical information from local systems110 and/or other data sources. The data warehouse portal 126 may providefunctionality related to data aggregation and/or data formatting thatallows multiple sources of medical information to be aggregated forpurposes of data analytics the like. In this regard, the data warehouseportal 126 may provide functionality resources as described in U.S.Provisional Patent Application No. 62/019,227 entitled “MANAGED MEDICALINFORMATION EXCHANGE” filed on Jun. 30, 2014, which is co-owned with thepresent application and is incorporated by reference herein in itsentirety.

A local system 110 may include a local database 112 for storage ofinformation. As may be appreciated, the local database 112 may in factinclude a collection of one or more databases collectively referred toas the local database 112. In an implementation of the presentinvention, the local system 110 may include a server that facilitatesaccess to the database 112. The database may store data related to thecurrent in process work and/or store archival data related to prior workcompleted at the pharmacy. The local database 112 may be ahigh-performance, highly scalable and SQL-compliant object database. Inthis regard, the database may scale easily to handle thousands ofsimultaneous users and potentially terabytes of data.

In addition to storing information related to pharmacy work (i.e., doseorder records), the database 112 may include information in a variety ofcontexts including information related to formulary information,administrative information, or other information related to the pharmacyworkflow management application 114 at the local system 110. In anyregard, the local system 110 may execute a number of services (e.g.,provided by modules executed by a processor). For instance, a databackup module may be provided that provides a rule-base approach to databackup from the local system 110 to the central server 120. The databackup module may define the interval at which the local system 110provides backup data to the central server 120 and/or may dictate whatinformation is provided to the central server. The backup module mayalso provide an administrator (e.g., at the central server or the localsystem 110) with information relating to the success or failure of databackup operations, system slowdowns, and the like. For instance, thebackup module may facilitate selective backup of the local database 112as described in U.S. Patent Application No. 62/019,227 incorporated byreference above.

Each local system 110 may also include a formulary management module 116that allows a pharmacy formulary to be maintained. As such, each localsystem 110 may have a formulary comprising a plurality formulary recordsstored at the local database 112. As may be appreciated, from time totime, formulary records within the formulary may need to be added,removed, or modified. In this regard, formulary management module 116may provide a formulary management tool for use in maintaining theformulary (i.e., the formulary records comprising the formulary). Theformulary records comprising the formulary may include records belongingto a number of categories of formulary records. For instance,corresponding records may be stored in relation to administrationroutes, drug categories, drugs, materials, product groups, and/orproducts. Collectively, these records may provide data to the pharmacyworkflow management application 114 for use in the preparation ormanagement of a dose order record. As discussed herein, the formularymanagement module 116 may provide functionality related to themanagement of the formulary records comprising the formulary.

With brief reference to FIG. 6, an embodiment of a user interface screenfor an embodiment of a pharmacy workflow management application 1300 isdepicted. The application 1300 may be a web-based management tool thatmay be presented to a user in a web browser or the like. For instance, auser may navigate to a particular web address and be presented with alogin screen 1302 as shown in FIG. 6. The login screen 1302 may includean authentication field 1304 that may require, for example, a user nameand password be entered by the user to facilitate confirmation of auser's authorization to utilize the application 1300 and/or accessvarious functionality of the application 1300. As may be appreciated,different user authorization levels may exist such that when a user logsin utilizing the authentication field 1304, various rights associatedwith the application 1300 may be allowed or blocked based upon the usercredentials provided and the associated authorization level associatedtherewith.

Additionally, the provision of user authentication information at thelogin screen 1302 may allow for a user profile for a given userassociated with the user authentication information to be identified. Inthis regard, the user profile may be associated with modifiablecharacteristics of the user interface of the application 1300. In thisregard, customizable or configurable elements of user interfacesdescribed herein may be associated with a user profile such that thedefault configuration may be defined for a user profile. Additionally oralternatively, user profile may be based upon the last status ofcustomizable or configurable characteristics of user interface. Forexample, as will be discussed in more detail below, a user profile mayindicate the configuration of one or more collapsible areas, which maybe configured to hide information (i.e., the user profile may indicatewhich of the collapsible areas are operable to hide information upon agiven user's initial system login). Further still, other user interfaceelements may be dictated based on a user profile. In any regard and aswill be described in greater detail below, various aspects orcharacteristics of the user interface of the application 1300 may be atleast partially based upon a user profile associated with userauthentication information provided to access the application 1300.

With further reference to FIG. 7, upon successfully authenticating theuser, a navigation screen 1306 may be provided to the user. Thenavigation screen 1306 may include a plurality of links associated withvarious functions of the application 1300. For example, the navigationscreen 1306 may facilitate access to a dose order record listing forreview or management of dose orders as described in greater detailbelow. Also, the navigation screen 1306 may facilitate access toverification screens typically used by a pharmacist to review and verifydoses that have been prepared in the pharmacy by a pharmacy technician,as are also described in greater detail below. The navigation screen1306 may also have a number of formulary management links 2200.Selection of any one of the formulary management likes 2200 may direct auser to a formulary management workspace 2210 as shown in FIG. 22.

The formulary management workspace 2210 may include a number ofnavigational tabs 2212. The navigation tabs 2212 may generallycorrespond to different categories of formulary records and/or formularymanagement functions associated with the formulary records. In thisregard, selection of one of the navigation tabs 2212 may result in theworkspace 2210 displaying a record listing 2214 that contains formularyrecords associated with the corresponding categories of formularyrecords associated with the selected navigation tab 2212. Additionally,the workspace 2210 may include a record detail portion 2216.

Accordingly, as depicted in FIG. 22, the navigation tab 2212corresponding with “Administration Routes” 2212 a has been selected. Inturn, formulary records associated with the category of administrationroutes are displayed in the record listing 2214. Selection of a givenrecord 2218 from the record listing 2214 may display details regardingthe record 2218 in a record detail portion 2216 of the workspace 2210.As will be appreciated from the discussion that follows, the recorddetail portion 2216 may include specific record detail fields. Notably,each of the specific records details may be altered without deleting thespecific record detail or adding a new record detail. That is, therecord details may be modified “in-line.”

As depicted in FIG. 22, the record detail fields for the administrationroutes 2212 a category may include an administration routes synonymsfield 2224. Each specific record detail field may comprise a collapsiblearea that is selectively collapsible or expandable by the user to hideor display the data contained within the given record data field. Forexample, the information associated with administration route synonymsdata field 2224, discussed in greater detail below, may be selectivelycollapsed or expanded by activating collapsible area button 2228. Eachspecific record detail field may also include a help icon, such as helpicon 2232 of administration route synonyms 2224. The help icon may beoperable to display context-specific information associated withinformation of each record detail portion 2216, respectively. It will beappreciated that each records detail portion 2216 of the variousdisclosed categories of navigation tab 2212 may include a collapsiblearea and help icon in an analogous manner.

Additionally, the record listing 2214 may be manipulated such that thecolumn headings, record groupings, or other configurable table elementsare modified in accordance with the discussion presented below inrelation to FIGS. 8-12 such as resizing, sorting, or filtering thecolumns of record listing 2214.

In this regard, various elements of the user interface comprising theworkspace 2210 may be modifiable, configurable, or customizable by theuser. In turn, default configuration in relation to these user interfacecomponents may be associated with the user profile. In turn, uponaccessing the workspace 2210, a given user associated with the userprofile may be presented a user interface having the user interfaceelements defined based on the user profile. Again, the user profile mayhave default configurations selectable by the user, or the user profilemay correspond to the configuration last displayed to the user. In anyregard, the user profile may span user access sessions such that asubsequent session is at least partially based on a previous session ora default configuration profile associated with the user profile.

The workspace 2210 may further include a search area 2220. Upon entry ofa query into the search area 2220, the record listing 2214 may befiltered such that a filtered table result may be displayed to the user.In this regard, upon entry of a query into the search area 2220,associations between the query provided in the search area 2220 and theplurality of formulary records displayed in the record listing 2214 maybe identified. In turn, the filtered table presented to the user may beat least partially based upon the associations between the queryprovided in the search area 2220 and the records listing 2214 such thatthe filtered results correspond with record listings 2214 having datamatching the query. The workspace 2210 may also include a plurality ofmaintenance operations buttons 2215 that are displayable with eachrespective navigation tab 2212 such that the maintenance operationsbuttons remain visible while the information of each category isscrolled. The maintenance operation button 2215 may include a button tocreate a new record for a given category of records, a button to deletea record, a button to modify a record, a button to save a modifiedrecord, a button to cancel modifications made to a record, a button tocreate a new record based on a selected record, or other appropriatebutton to take a specific action with respect to a record.

Returning to the discussion of FIG. 22, upon selection of a record 2218corresponding to the administration route category 2212 a, the recorddetail portion 2216 may include an administration route synonyms field2224. A user may provide synonyms related to the selected administrationroute record 2218 by providing this information in the administrationroutes synonyms field 2224.

With further reference to FIG. 23, the “Drug Categories” tab 2212 b isselected. In turn, formulary records associated with the drug categoriescategory of formulary records are displayed in the record listing 2214.Upon selection of a given one of the records 2218, details regarding therecord are displayed in the record detail portion 2216. The recorddetail portion 2216 shown in FIG. 23 that corresponds to the formularyrecords associated with the category of drug categories 2212 b mayinclude a field related to drug category properties 2316. In turn, usermay provide details regarding a category name and category descriptionrelated to the selected one of the drug categories selected from therecord listing 2214.

With further reference to FIG. 24, a “Drugs” tab 2212 c is selected. Inturn, formulary records associated with the category of drugs aredisplayed in the record listing 2214. Upon selection of a given one ofthe records 2218, details regarding the record are displayed in therecord detail portion 2216. The record detail portion 2216 shown in FIG.24 that corresponds to the drug formulary record category may includefields related to drug properties 2316, expiration profiles 2320,synonyms 2324, categories 2328, contained product information 2332, andspecial instructions for the selected record 2336. As may be appreciatedin FIG. 24, each of these fields are collapsed. With further referenceto FIGS. 25-28, respective ones of these fields are shown in an expandedconfiguration.

For instance, in FIG. 25, the drug properties field 2316 has beenexpanded. In turn, a user may provide a drug name for the selectedrecord 2218 in the record listing 2214 (e.g., shown in FIG. 24).Additionally, user may indicate whether the selected drug correspondswith a hazmat drug, a high risk drug, whether the drug is allowed as adiluent, or whether the drug requires review. Furthermore, auxiliarydata fields are provided for additional information regarding theselected record 2218 to be provided.

FIG. 26 depicts the expanded expiration profiles field 2320 and synonymsfield 2324. In the expiration profiles field 2320, expiration profilesregarding the selected drug formulary record 2218 may be provided. Theexpiration profile may define a time after which a drug expires fordifferent circumstances. For example, as shown in FIG. 26, the selecteddrug record may have expiration profile of 72 hours if the drug ismaintained at room temperature. Further expiration profiles may bedefined relative to variables such as the nature of the storage of thedrug, the diluent used, the concentration of the drug, or other relevantcharacteristics that affect expiration profile of a drug. FIG. 26 alsodepicts a synonyms field 2324 in expanded form. In the synonyms field2324, user may define synonyms for the selected drug record.

FIG. 27 depicts the expanded categories field 2328. In this regard, auser may provide a selection of drug categories (e.g., from the listingof drug categories displayed in FIG. 23) to which the selected drugrecord 2218 is associated. Additionally, the contained productinformation field 2332 is expanded in FIG. 27. The contained productfield 2332 may allow for a user to define products (e.g., from a listingof product records contained in the formulary as described in greaterdetail below) that contain the drug corresponding to the selected drugrecord 2218. With further reference to FIG. 28, the special instructionsfield 2336 is also expanded. In this regard, user may provide specialinstructions with respect to the selected drug record 2218.

FIG. 29 depicts the workspace 2210 when the “Materials” tab 2212 d isselected. In turn, formulary records in the materials category aredisplayed in the record listing 2214. Upon selection of a selectedrecord 2218, the record detail portion 2216 may include an expandableand collapsible material properties field 2916. The materials propertiesfield 2916 may allow for a user to define a material name and mayinclude various auxiliary property information regarding the selectedmaterial record 2218.

FIG. 30 depicts the workspace 2210 when the “Product Groups” tab 2212 eis selected. Upon selection of the product groups 2212 e navigation tab2212, formulary records associated with the product groups category aredisplayed in the record listing 2214. Upon selection of a given record2218, the record detail portion 2216 may allow for modification ofdetails regarding the record in a product group properties field 3016and a group products field 3020. The product group properties field 3016may allow for a group name and description to be provided to theselected group record 2218. The group products field 3020 may allow forproduct records (e.g., as described below) to be associated with theselected product group 2218.

FIG. 31 depicts the workspace 2210 when the “Products” category tab 2212f is selected. Upon selection of the “Products” category tab 2212 f ofnavigation tab 2212, formulary records corresponding with formularyrecords in the products category are displayed in the record listing2214. Selection of a given product record 2218 allows for themodification the product record in the record detail portion 2216. Anumber of expandable collapsible fields are provided in relation to theproducts records. For example, expandable fields may include a productproperties field 3116, a national drug code (NDC) field 3120, a productdrugs field 3124, beyond use date field 3128, a diluent restrictionsfield 3132, an administration routes field 3134, a product group field3138, a special instructions field 3142, and an additional informationfield 3146. With further reference to FIGS. 32-34, the various ones ofthese fields are shown in an expanded configuration.

For instance, with reference to FIG. 32, the product properties field3116 is shown in an expanded configuration. In turn, user may providedetails for the selected product record 2218 including the product name,the product type, a procedure with which the product is associated(e.g., for presentation of a protocol related to the product to a userfor use with making the product), the reconstituted volume of theproduct, the stocking location of the product, the total volume of theproduct, the dose form associated with the product, a label profileassociated with the product, a strength/description of the product,synonyms for the product, default storage methods for the product,specific gravity of the product, and a selection of whether to print averification label for stock or dilution doses. Furthermore, the usermay select whether the product is active, a multidose product, a premixproduct, a preservative free product, relates to a stock order, whetherthe product relates to a dilution, or whether the product needs review.

FIG. 32 also shows the NDC field 3120 in an expanded configuration. TheNDC field 3120 allows the user to provide barcode or NDC data (e.g., 10digit or 11 digit NDC data) related to the product. Also, the NDC fieldmay allow for a user to input a given NDC for a product and allow forgeneration of a NDC code based on a 10 digit to 11 digit NDC conversionas discussed in U.S. provisional Patent Application No. 61/975,519,incorporated by reference above.

FIG. 33 depicts the product drugs field 3124 in an expandedconfiguration. The product drugs field 3124 allows for a drug (e.g., adrug record as shown in the record listing 2214 when the drugsnavigation tab 2212 c selected) to be identified as being containedwithin the selected product record. The beyond use date (“BUD”) field3128 is also expanded in FIG. 33. The BUD field 3128 may allow a user toidentify a time period (e.g., in hours and minutes) beyond which aproduct, once prepared, expires. FIG. 33 also depicts a diluentrestrictions field 3132. The diluents restriction field 3132 allows auser to identify acceptable diluents used to prepare the productcorresponding to the selected product record 2218. The diluentsrestrictions field 3132 also provides an “Allow All Diluents” selectionwhereby all available diluents may be selected. Alternatively, selectedones of the diluents in the all diluents field may be selected forinclusion the selected diluents field. In this instance, only theselected diluents appearing in the selected diluents field may beidentified as an appropriate diluent for the product corresponding tothe selected product record 2218.

In FIG. 34, the administration routes field 3134, the product groupfield 3138, the special instructions field 3142, and additional infofield 3146 are shown in expanded format. In the administration routesfield 3134, appropriate administration routes (e.g., selected from thelist of administration routes shown in FIG. 22) for the selected productrecord may be selected. Again, an “Allow All Routes” selection may beprovided that allows a user to select all available administrationroutes. Alternatively, selected ones of the administration routes (e.g.,the administration routes appearing in the record listing 2214 uponselection of the administration routes navigation tab 2212 a as shown inFIG. 22) may be selected by including the appropriate administrationroute from the All Routes field into the Selected Routes field isdisplayed in FIG. 34. The product group field 3138 may allow for aproduct group (e.g., a product group is appearing in the record listing2214 upon selection of the product group navigation tab 2212 e) may beselected to identify the product group to which the selected productrecord 2218 belongs. The special instructions field 3142 allows for theuser to provide special instructions with respect to the selectedproduct record 2218. Furthermore, the additional information field 3146may allow for the user provide additional information regarding theselected product record 2218. Examples of additional information thatmay be provided by the user may include a vendor name of the product, awholesaler of the product, a brand name of the product, a cost of theproduct, a URL associated with the product, a URL description associatedwith the product, a comment associated with the products, or a number ofauxiliary fields used to describe the characteristics or otherinformation related to the product.

Accordingly, it may be appreciated that the formulary for a given localsystem 110 may be managed by way of the formulary management workspace2210. In this regard, various formulary records corresponding todifferent formulary record categories may be selectively displayed,modified, added, or deleted, using the workspace 2210. In turn, upon theaddition of records belonging to one or more categories such asadministration routes, drug categories, drugs, materials, productgroups, products, a user may access the formulary management workspace2210 and perform the necessary modifications to the formulary recordsstored at the local database 112 to reflect the update to the formulary.

With further reference to FIG. 2, a schematic view of an embodiment of alocal system 110 in operative communication with a central server 120 isdepicted. Again, the local system 110 may execute a pharmacy workflowmanagement application 114 for processing dose orders to preparecorresponding doses for administration to a patient (e.g., at leastpartially based on the formulary records of the local system). As may beappreciated, the local system 110 may, in at least one embodiment,include a pharmacy information system 320. The pharmacy informationsystem 320 may communicate to a local server 330. The local server 330may store and/or provide access to the local database 112. A labelprocessing module 332 may be provided in operative communication withthe pharmacy information system 320 and the local server 330. The labelprocessing module 332 may intercept a message or data stream from thepharmacy information system 320. In turn, the label processing module332 may provide data to the local server 330 for creation of a doseorder record at the local server 330 in response to the label processor332 receiving dose order information from the pharmacy informationsystem 320.

As such, the local system 110 (i.e., a pharmacy, hospital, or otherfacility capable of preparing doses for administration to a patient) mayreceive or generate dose orders. Dose orders may be received at thelocal system 110 in one or more different ways. By way of example, in anembodiment a doctor or other appropriate medical personnel may enter oneor more dose orders directly using the pharmacy information system 320.In this regard, the pharmacy information system 320 may provide anappropriate terminal that is accessible by the appropriate medicalpersonnel for entry of the dose order (e.g., a physician order entry“POE” system or terminal, etc.). Additionally or alternatively,appropriate medical personnel may enter dose orders at a remote accessterminal 314 that may provide order data to the label processor 332 inthe local system 110 by way of the wide area network 50. As may beappreciated, the remotely entered dose orders may be communicated to thelabel processor 332 by way of a local server 330. In this regard, thelocal server 330 may include web services that facilitate thecommunication of dose orders from the remote access terminal 314 to thelabel processor 332. As the remote access terminal 314 may be remotefrom the local system 110, one or more routers and/or firewalls beprovided to assist in providing and securing the communication betweenthe remote access terminal 314 and the local server 330. Further still,the pharmacy information system 320 may receive dose orders from and/orbe a component of a larger hospital information system that may becapable of receiving and/or generating dose orders. In this regard, thehospital information system may provide information to the pharmacyinformation system 320 and/or directly to the label processor 332 asdescribed in greater detail below. Any communication into or out of thelocal system 110 and/or any communication within the local system 110may be secure. For example, various security protocols such as https,SSH, VPN, DES encryption, RSA encryption, or any other known securityprotocol to secure communication between nodes in the network.

In any regard, the pharmacy information system 320 may receive data fromwhich information related to one or more dose orders may be extracted.That is, dose orders corresponding to requested doses for administrationto a patient may received at the local system 110 and routed to thelabel processor 332. While present disclosure generally includes adescription of label processing, label processing module may also be ofany type described in commonly assigned U.S. Pat. No. 7,069,212, whichis hereby incorporated by reference in its entirety.

In traditional approaches to pharmacy management, when dose orders arereceived at a facility, a corresponding physical label for the doseorder is printed within the pharmacy. In turn, traditional workflowmanagement in the pharmacy is relegated to management of physicallabels, which may be disadvantageous in that the physical labels may belost, the physical labels may be difficult to organize, the use ofphysical labels introduces additional potential for human error, and theproduction of physical labels may not provide reliable logging for laterauditing.

In contrast, when the dose orders are processed by the label processor332, rather than only a label for medication order being printed, datarelated to the order (e.g. data that have traditionally been printed onthe label corresponding to the order) may be captured, processed, andparsed in the computer implemented system to create individual medicaldose order records, each of which corresponds to a corresponding doseorder, that are in turn stored in the local server 330. That is, ratherthan only printing a label for a medication order, the order may beutilized to generate a digital dose order record that is stored at thelocal server 330 (i.e., in the local database 112). Data used togenerate the digital dose order record may be taken from the medicationorder data received at the local system 110. As such, a dose orderrecord may be generated and stored at the local server 330 thatcorresponds to each given medication order received at the local system110. Thus, rather than having to manage physical printed labels at thelocal system 110, the received medication orders may be manageddigitally utilizing the local server 330 that stores the dose orderrecords corresponding to each medication order received.

With reference now to FIG. 3, an embodiment of process is illustrated inwhich dose orders are received and processed to generate and store doseorder records at the local system 110. At step 200, one or moremedication order streams are received at the local system 110 (e.g.,from a local data stream or a remote data stream as described above) andare processed by a label processing module 332. The label processingmodule 332 may comprise a processor that accesses a memory comprisingcode that is executed by the processor (e.g., at the local server 330)to perform the processes in FIG. 3. That is, the label processing module332 may be separate from or comprise a part of the local server 330. Inone specific embodiment, the medication order data can be captured by amonitoring module comprising computer code executing on a processor inthe pharmacy for monitoring a port normally connected to a pharmacyprinter, network monitoring for medication order information, orsoftware application monitoring for events related to the input ofmedication orders. As described above, traditionally these order streamsmay represent data intended to be printed on labels on a printer, andoftentimes comprise serial data streams.

The medication order streams may contain a list of medication doses toprepare. Each dose order and dose may be associated with additionalrelated data such as, for example, the patient for whom the medicationis intended, by when the dose should be delivered, to where the doseshould be delivered, the ordering doctor, the time and date the doseorder was entered, the reason for medication, and other relevantinformation associated with the dose order or any other appropriatemetadata described in further detail below that may be present in themediation order stream for each dose order contained in the stream. Suchinformation may be used when generating a dose order record to populateappropriate dose order record data fields for a dose order record thatcorrespond to respective ones of the medication dose orders contained inthe medication order streams. As will be discussed in greater detailbelow, additional dose order metadata may be added to the dose orderrecord during the preparation, approval, and/or distribution of the doseorder that corresponds to the dose order record. The dose order recordand all related dose order metadata may be stored in the local database112.

Data streams containing medication dose order data that are received atthe local system 110 are preferably logged at step 202 by a monitoringcomputer. Preferably, streams are logged in the local database 112 orother computer accessible medium (e.g., at the local server 330).Logging data streams enables extensive auditing and monitoring of thepharmacy, hospital, or other facility that prepares and/or the dose.Because all data is logged, preferably in its raw form when it is firstreceived by the pharmacy, no information is lost, corrupted, ordisassociated during the processing or distribution of the medication.If necessary, an audit can be performed manually, off-line, or by aseparate software program to reconstruct the data stream and allprocessing that should have or did occur after the pharmacy received thedata stream.

Preferably, a data stream containing dose orders that is received at thelocal system 110 has an identifiable source. The source can beexplicitly identified within the stream of data, or it can bedeterminable by the system. Source determination can include, forexample, examining TCP/IP packet or header/footer information, examiningcryptographic signatures of the stream, or data retrieved throughadditional network communication requesting the source. In any regard,the source may be identified at step 204.

At step 206, the system may be configured to determine whether the datastream originated from one of a set of valid sources. This can includeidentifying the source of the data stream and testing that it is one ofthe sources among those in the set. Validating the source ensures eachmedication dose prepared by the pharmacy workflow management application114 is legitimate and originating from an authorized prescribing orordering entity. Alternatively, the validation can ensure that theprescribing entity is presently entitled to have its prescriptionsfilled by the pharmacy. If the source is not valid, the system returnsto step 200 to receive additional streams. Optionally, notifications canbe sent to the source to inform it that there were validation issues orthat the window for continued validation has one or more constraints(e.g., will expire in so-many days due to an overdue invoice).

After determining that the source is valid, the stream may be parsed toextract relevant information at step 210. The system can parse variousmessage and data formats. Moreover, the parser can be extensible, suchthat as new formats are implemented or included within the networkedenvironment, a parser extension can be included in the system to parsethe new format. For example, if the data stream is a serial printer datastream, the system can determine the format of the data and pass thestream to the appropriate serial printer data parser. The printer dataparser is configured to extract the dose order information containedwithin the stream and may populate dose order record data fields of adose order record with the parsed data from the data streamcorresponding to any one or more portions of dose order metadatadescribed in more detail below. Preferably, the parser extracts allrelevant data contained within the stream and maintains a record of theextracted data. The parsing methodology is preferably encapsulated in alibrary or set of modules that are called upon, as necessary, to parse astream of any determined format. Each library entry or module operatesas a “parser,” as that term is used herein.

As described above, the data stream may contain one or more dose orders.For example, the stream may contain a single dose request by a doctorfor a single patient. Alternatively, the stream can include multipledose orders that may be delineated by the parser into separate doseorder records corresponding to each distinct dose order. That is, theparser is preferably configured to recognize and discriminate betweenindividual dose orders within a stream. In turn, dose order records maybe created and populated for each corresponding one of the individualdose orders within a stream. The discrimination of individual doseorders can be accomplished by recognizing an order delimiter, oralternatively can be defined by the format of the data stream.

In any regard, once the stream is parsed at step 210, a dose orderrecord may be created at step 220. In turn, the dose order record may bestored at the local database 330 at step 222. In this regard, the datastream may be received 200, logged 202, and parsed 210 to create acorresponding dose order record for each dose order contained within thestream. In turn, the medication stream received at the local system 110may be used to generate dose order records stored in a local server 330for each medication dose order to be prepared at the local system 110.

As briefly described above, having dose order records stored digitallyin the local database 330 may facilitate improved management of the doseorder records in the pharmacy. In turn, the following describes someembodiments of dose order record management performed at the localserver 330 to facilitate pharmacy workflow management by the pharmacyworkflow management application 114. Specifically, dose order recordsmay be easily viewed, sorted, searched, prioritized, or otherwiseorganized by pharmacy technicians or other personnel who haveappropriate access to the local database 330. Furthermore, as data isgenerated in the pharmacy regarding the dose order (e.g., during thepreparation, approval, or distribution of a dose), such data may bestored in relation to the medication dose order record to provide a morerobust data set associated with each medication dose prepared at thepharmacy. As may be appreciated, the amount of data related to eachdigital dose order record may be extensive. The data related to the doseorder record may be referred to as dose order metadata. In turn, doseorder metadata may be stored in corresponding dose order record datafields and may describe various characteristics of the dose order, adose corresponding to the dose order, the preparation of a dose, orother relevant characteristics related to the dose or dose order. Insome embodiments, the dose order metadata may facilitate dose orderingtracking via triggered scan events, as discussed in more detail below.

For instance, examples of dose order record data fields may include, butare not limited to:

-   -   dose order status information indicative of at least one of:        -   a preparation status of the dose order (e.g., pending, at            preparation station, ready for verification, undergoing            verification, approved, rework, requeue, awaiting sort,            discontinued, etc.),        -   a priority status of the dose order (e.g., STAT, first dose,            etc.),        -   a wait status (e.g., including a time at which the dose            order become available to be made),        -   a hold status,    -   dose order administration data indicative of at least one of:        -   a patient to whom the dose order is to be administered,        -   a time of administration (e.g., including date and time of            administration),        -   a beyond use date (BUD) indicative of an expiration (e.g.,            time and/or date) of the dose order,        -   an administration route of the dose order,        -   a preparation mode of the dose order,    -   dose order identification information indicative of at least one        of:        -   a dose order identifier (e.g., a dose order record number),    -   medication source data indicative of at least one of:        -   a manufacturer of a component of a product corresponding to            the dose order,        -   a lot number of a component of a product corresponding to            the dose order,        -   an expiration date of a component of a product corresponding            to the dose order,        -   a serial number of a component of a product corresponding to            the dose order, or        -   a drug code indicative of the identity of a component of a            product corresponding to the dose order;    -   chain of custody data indicative of at least one of:        -   a listing of entities in possession of a component of a            product corresponding to the dose order or a product            corresponding to the dose order,        -   a listing of users that have taken an action with respect to            a product corresponding to the dose order, wherein the            listing of users is correlated to specific actions taken by            each user, or        -   tracking information corresponding to physical movement of a            component of a product corresponding to the dose order or a            product corresponding to the dose order;    -   fulfillment data indicative of at least one of:        -   image data corresponding with a component of a product            corresponding to the dose order or a product corresponding            to the dose order,        -   scanned data obtained from a component of a product            corresponding to the dose order,        -   analytic data regarding a component of a product            corresponding to the dose order or a product corresponding            to the dose order,        -   pharmacist review data corresponding with at least one            pharmacist review of a component of a product corresponding            to the dose order or a product corresponding to the dose            order,        -   compliance data corresponding with best practices associated            with a component of a product corresponding to the dose            order or a product corresponding to the dose order,        -   sterility assessment data corresponding to a component of a            product corresponding to the dose order or a product            corresponding to the dose order,        -   a listing of actions corresponding to a component of a            product corresponding to the dose order or a product            corresponding to the dose order,        -   timestamp data corresponding to actions corresponding to a            component of a product corresponding to the dose order or a            product corresponding to the dose order, or        -   a listing of life cycle events taken with respect a            component of a product corresponding to the dose order or a            product corresponding to the dose order; or    -   environmental data indicative of at least one of:        -   a temperature to which a component of a product            corresponding to the dose order or a product corresponding            to the dose order has been exposed,        -   a temperature to which and corresponding time period for            which a component of a product corresponding to the dose            order or a product corresponding to the dose order has been            exposed,        -   whether a component of a product corresponding to the dose            order or a product corresponding to the dose order is            refrigerated,        -   whether a component of a product corresponding to the dose            order or a product corresponding to the dose order is            frozen,        -   a temperature profile experienced by a component of a            product corresponding to the dose order or a product            corresponding to the dose order, or        -   accelerometer data corresponding to forces experienced by a            component of a product corresponding to the dose order or a            product corresponding to the dose order.

Furthermore, because the dose order records are stored digitally at thelocal server 330, remote access be provided to those outside of thepharmacy to view, modify, and/or otherwise manage the digital dose orderrecords stored at the local server 330. In turn, access to the dataassociated with the medication dose order records may be provided toremote users to assist in the management of pharmacy resources or thelike. Accordingly, as will be discussed herein, a number of approachesto pharmacy workflow management may be facilitated that utilize themedication dose order records stored in the local server 330.

With returned reference to FIG. 2, the local server 330 may be inoperative communication with one or more local clients at the localsystem 110. For instance, the local client may comprise thick or thinclients executing at a terminal or workstation. In this regard, thepharmacy workflow management application 114 may comprise a web servicesapplication provided by the local server 330 accessed at a thin clientby way of a web server.

Additionally or alternatively, the pharmacy workflow managementapplication may include thick client applications executing at a clientthat may communicate with the local server 330. The client applicationsmay be provided at one more terminals locally at the local system 110and/or remote from the local system 110. For instance, a clientapplication may be provided on workstations that are equipped to preparedoses or terminals that provide access to information stored on theclient server 330. The terminals executing the client application mayinclude management terminals that may access and/or modify dose orderrecords, review terminals that may allow a pharmacist to review doses, asituation board that displays relevant pharmacy information, or otherappropriate terminals that facilitate functionality related to thepharmacy workflow management.

In the specific context of a thick client, the pharmacy workflowmanagement application executing at the terminal may, from time to time,require updating. In traditional approaches to updating the thick clientat a given terminal at the local system 110, a support user or the likewith access privileges to update equipment at the local system 110 maybe required to login to each terminal for upgrading of the thick clientat each terminal. However, as contemplated herein, a terminal executinga thick client may allow for installations without the need foradministrator privileges. Specifically, the version of the thick clientat the terminal (e.g., workstation) may be compared with a currentversion of the thick client software stored locally at the client server330. In this regard, the version of the thick client may be compared tothe current version of the thick client software available at the clientserver 330. If the thick client software is out of date, a user of thethick client (e.g., without administrator rights to update the clientserver 330) may be presented an option to download the updated thickclient version to the terminal. The updated thick client version may bedownloaded to the terminal and installed thereon in response to arequest by the user to do so. In turn, the updating of thick clientswithin the local system 110 may be streamlined in that a user withadministrative privileges may simply be required to load a singleupdated version of the thick client software to the client server 330.In turn, upon access of the terminals executing a thick client byordinary users (e.g., users without administrative privileges relativeto the client server), the user of the client may be presented theoption to update the thick client version at the terminal.

In the case of locally resident terminals, the communication between thelocal server 330 and the locally resident terminals may includecommunication over a local area network or the like. In this regard,operative communication may be established between a terminal and thelocal server 330 over a local area network. In an embodiment, thecommunication between the locally resident terminal and the local server330 over the local area network may be cryptographically manipulated(e.g., encrypted). In this regard, communication over the local areanetwork may provide a secure data connection between the locallyresident terminal and the local server 330. Specifically, datacommunicated between the locally resident terminal and the local server330 may be translated into an illegible format when communicated. Thismay help to prevent third-party interference with the data communicatedbetween the locally resident terminals and the local server 330. In oneexample, the encryption of the data transmitted between the locallyresident terminal and the local server 330 may be a secure socket layer(SSL) protocol.

In an embodiment, at least one of the terminals may be provided as aremote access terminal 314 to facilitate access to the local server 330from outside the local system 110. Such remote access by a client may befacilitated by way of secure communications (e.g., use of secure socketlayer (SSL) communication, encryption, or other means of securecommunication over a network such as those described above).Accordingly, once appropriate security measures of been taken, theremote access terminal 314 may execute a client application operable tocommunicate with the local server 330 in a manner similar to the localinstances of a client within the local system 110. That is, the remoteaccess terminal 314 may be provided with any or all the functionalityassociated with any of the local client device is described herein.

Given the foregoing architecture at the local system 110 where clientsmay access the local server 330 to manage various features of thepharmacy workflow management application, it may be appreciated that thelocal system 110 may be scalable with the addition of additionalterminals, each executing a thick or thin client in operativecommunication with local server 330. Also, the architecture allows forremote access as described above. Further still, access by a terminalmay be subject to the role-based security described above. That is,because dose order records stored locally at the local database 112 andare accessed by way of the client application, the management of thedose order records may be substantially simplified. For instance, whilea client application may modify dose order record, the modification tothe dose order record will be reflected at the local database 112. Inturn, another terminal in operative communication with a local database112 may be configured to receive updated data from the local database112 (e.g., in substantially real-time) such that the modification of thedose order record from the client application may be reflectedthroughout the terminal with access to the local server 112. Thisdistributed model of dose order record management may provide robustcapabilities, especially in the context of collaborative management doseorder records.

A workstation (i.e., a terminal where doses are prepared) may include atouchscreen, one or more barcode scanners, a label printer, a camera,etc. Additional hardware that may be present at the workstation mayinclude a scale, a reconstitution module (mixing station) and/or asecurity ID badge reader. The hardware at the workstation may beoperative to collect information regarding the preparation of a dosethat may be stored in corresponding relation to the dose order record.Furthermore, the workstation may include traditional preparationapparatus used to prepare doses such as, laminar flow hoods, biologicalsafety cabinets, or other pharmacy equipment used in the preparation ofa dose.

In any regard, the local server 330 may be in bidirectionalcommunication with any number of workstations to allow the workstations(e.g., 500, 510, 520, etc. as shown in FIG. 2) to receive informationfrom the local server 330. For instance, each workstation may receivedata regarding the dose order records stored at the local database 112by way of the local server 330. This data may include all dose orderrecords, collectively referred to as the dose order queue, stored at thelocal server 330 or may comprise a filtered dose order listing that onlydisplays a selected number of dose order records from the dose orderqueue at a given workstation, referred to herein as a dose order recordlisting.

In turn, with reference to FIG. 4, once the dose orders have beenprocessed 410 and provided dose order records stored in the localdatabase 330, the pharmacy workflow management application 114 mayprovide for dose queue management and prioritization 420. Accordingly,an embodiment of dose queue management and prioritization 420 isdescribed below.

For example, at each workstation or other terminal, the dose order queuemay be sorted and displayed as a dose order record listing that includesthe dose orders records in any number of different ways. For example,the dose orders can be sorted and displayed by drug type and can befurther sorted by dosage amount as shown in FIG. 5. The total amount ofdose orders for each drug can be displayed next to the drug name in amain banner 301 and then underneath the main banner, the various drugdosage amounts are listed along with the quantity of each that iscurrently needed (lines 303). For example, as shown in FIG. 5, the mainbanner shows that there are 34 orders for the drug Cefazolin andunderneath, the various drug dosage amounts, such as Cefazolin 1000 mg;Cefazolin 100 mg; Cefazolin 200 mg, are listed along with the quantitythat is needed for each. Other examples of interfaces for filtering,displaying, and/or otherwise managing a dose order record listing arepresented below.

Each dose order record listing can be displayed in a different manner toindicate information that is intended and helpful to the operators atthe one or more workstations that process and fulfill the dose orders.For example, on the left column of the screen that is shown in FIG. 5, abox 305 labeled “DC” stands for discontinued dose orders which areorders that have been discontinued for some various reason andtherefore, do not need to be processed and fulfilled. The box can havean associated color, such as purple, that allows individual dose ordersto be indicated as being discontinued and therefore, should not beselected for processing and fulfillment. For example, the Cefazolin 500mg (Qty: 8) dose order line can be displayed in purple, therebyindicating that this dose order is discontinued and should not beprocessed. Also along the left column are other status indicators, suchas “STAT” 307, “First Dose” 309, “Unknown Drug” 311, “Make Now” 313 and“Wait” 315. These indicators can dictate a preferred order of selectingand fulfilling the dose orders. The status indicators may be stored asdose order metadata for a dose order record. The status indicators maybe updated throughout the preparation process to provide the dose orderrecord a different status based on the progress through the preparationprocess. Additionally, “First Dose” can indicate the highest prioritydose orders which should be selected first before another dose order,including those dose orders that are labeled “STAT”. Meanwhile, asituation board 400, illustratively depicted on FIG. 47, provides anoverview of the queue for all drug orders that are being handled. Thesituation board 400 may provide an overview throughout the entireprocess of order preparation as shown in FIG. 4.

In addition and with returned reference to FIG. 5, other optionsavailable for selection by the operator at a station can be displayed,such as along the left column. For example, one or more filters 317 canbe employed by the operator to filter the dose orders that are listed inthe dose order queue. The filter 317 can be selected among standardones, such as a filter that lists only those dose orders that canselected and fulfilled by the operator at a given workstation or thefilter can be designed to only show only those dose orders that areclassified as STAT orders and/or those that are classified as First Doseorders. Alternatively, the filter can be a custom filter that is createdand defined by the workstation operator.

The dose order queue may also be displayed at a remote access terminal314. Thus, the remote access terminal 314 may be operative to displaythe dose order queue according to the foregoing (e.g., where dose ordersmay be sorted and/or filtered for display). Furthermore, anadministrator with proper administrative privileges may be operable tomanage the dose orders contained in the dose order queue. As may beappreciated, this management may be facilitated within a terminal withinthe pharmacy 310 or by way of a remote access terminal 314.

With reference to FIGS. 6-12, additional embodiments of various userinterface screens for an embodiment of a pharmacy workflow managementapplication 1300 are depicted. As described above, the application 1300may include a web-based management tool that may be presented to a userin a web browser or the like. For instance and as described above inrelation to accessing the formulary management workspace 2210, a usermay navigate to a particular web address and be presented with a loginscreen 1302.

With additional reference to FIG. 7, upon successfully authenticatingthe user, a navigation screen 1306 may be provided to the user. Thenavigation screen 1306 may include a plurality of links associated withvarious functions of the management in addition to the links 2200described above in relation to the formulary management workspace. Forexample, the navigation screen 1306 may facilitate access to a doseorder record listing for review or management of dose orders. Also, thenavigation screen 1306 may facilitate access for a pharmacist toverification screens used to review and verify doses that have beenprepared in the pharmacy by a pharmacy technician as are described ingreater detail below. The navigation screen 1306 may include a link 1308to a dose order management screen 1310. Selection of the link 1308 mayresult in the user being presented with the dose order management screen1310 shown in FIG. 8.

The dose order management screen 1310 may include a dose order recordlisting 1312 that displays appropriate ones of the dose order records ofthe dose order queue stored in the local server 330. The dose orderrecord listing 1312 may be arranged such that the individual dose orderrecords are listed and divided by columns wherein each columncorresponds with a different dose order record data field. As such, eachdose order record data field column may be used to sort the dose orderrecords in the dose order record listing 1312 (e.g., based on dose ordermetadata for each dose order record appearing in the dose order recordlisting). For example, the columns shown in FIG. 8 correspond to a doseidentifier, does description, administration time, a relative time toadministration, patient ID, patient name, patient location, a dosestatus, and a dose priority. In this regard, if desired the columnsdisplayed in FIG. 8 may be used to sort the dose order record listing1312 in ascending or descending order relative to the selected column.

The user may also utilize the dose order management screen 1310 tofilter the display of the dose order record listing 1312. For example,the dose order management screen 1310 may include one or more tabs (e.g.1314, 1316, etc.) that may be utilized to filter the dose order recordlisting 1312 according to status of the dose order records. For example,selection of tab 1314 by the user may filter the dose order recordsappearing in the dose order record listing 1312 such that dose orderrecords with a status of “pending” may be displayed (i.e., includingdose order records that have not yet been prepared). In this regard,selecting the tab 1314 may filter the dose order record listing 1312such that dose order records but not yet been prepared may be shown.Selection of the tab 1316 may result in filtering of the dose orderrecord listing 1312 such that dose order records are shown that haveundergone preparation and are waiting verification by pharmacist. Inthis regard, the dose order records having a status indicating the doseorders are awaiting verification by a pharmacist may only be displayedin the dose order record listing 1312. It may be appreciated thatadditional tabs may be provided corresponding with different dose orderstatuses such as, for example, doses at initial review (i.e., doses notyet having been released for preparation), doses ready for preparation,doses awaiting in-line verification, verify doses awaiting sorting,doses awaiting rework, or any other appropriate status identifier thatmay be attributed to the dose order record.

The tabs 1314 or 1316 may also provide a user with a changeablegraphical element that may allow for the user to be updated regardingvarious high-priority doses being added to the dose order record listing1312. For example, if a STAT dose is populated into the dose orderrecord listing 1312, a corresponding STAT dose indicator in the tab 1314or 1316 may be updated to display the number of STAT doses currently inthe dose order record listing 1312. Furthermore, the color indicator maybe used to provide a quick reference to the user. For example, if a STATdose is contained in the dose order record listing 1312, the STAT fieldin the tab 1314 or 1316 may be highlighted with a colored background(e.g., a red background that may be easily identifiable by the user evenif not in close proximity with a display displaying the dose ordermanagement screen 1310).

The dose order management screen 1310 may also include a plurality ofsecondary filters 1318 that may be utilized to further filter the doseorder record listing 1312. For example shown in FIG. 11, the secondaryfilters may include a selection of all doses, requeued doses, STATdoses, resume preparation doses (e.g., doses is preparation have beeninterrupted), rework doses, discontinue doses, doses placed on weightand/or hold, and suspected duplicate doses. It may further beappreciated that the secondary filters 1318 provided may be based uponthe tab 1314 or 1316 selected. For example, when the tab 1314 isselected for display of dose order records that have not yet beenprepared, the secondary filters 1318 displayed may include those listedabove including an all dose filter, a requeued dose filter, a STAT dosefilter, a resume preparation dose filter, a rework dose filter, adiscontinued dose filter, a wait/hold dose filter, and a suspectedduplicate dose filter. However, upon selection of tab 1316 to displaydose order records that have been prepared and are awaitingverification, the secondary filters 1318 may be modified to include await/hold filter, and in-line filter (e.g., to only display dosesawaiting in-line verification), a STAT filter, a final verificationfilter, and a being verified filter. A queue filter 1336 may also beprovided to allow for configurable filters to be generated and appliedto the dose order record listing 1312 based on a configurable comparisonof the dose order queue to predetermined dose order record data fieldvalues as will be described in greater detail below.

Returning to FIG. 8, it may be appreciated that a dose order record 1320may be selected from the dose order record listing 1312. The selecteddose order record 1320 may be signified by a checkbox provided in thedose order record listing 1312 and/or highlighting of the selected doseorder record 1320 from among the other dose order record in the doseorder record listing 1312. As may be appreciated, multiple dose orderrecords may be highlighted has selected dose order records 1320 suchthat batch processing may be facilitated on selected ones of the doseorder records 1320. Selection of the selected dose order record 1320 mayresult in a plurality of dose order operation buttons being enabled. Forexample, dose order operations buttons may include a detail button 1322,a place on hold button 1324, a remove from hold button 1326, adiscontinue button 1328, and modify button 1330. Selection of a doseorder operation button by a user may result in performance of acorresponding operation to the selected dose order 1320. For example,selection of the detailed button 1322 may result in the dose ordermanagement tool 1300 displaying a dose detail screen 3500 as shown inFIG. 35 that provides additional details regarding the selected doseorder 1320.

With further reference to FIG. 35, the dose detail screen 3500 mayinclude a number of navigation tabs 3510 to allow for navigation tovarious portions of information regarding the selected dose order 1320.In FIG. 35, the summary tab 3512 is selected. In turn, the dose detailscreen 3500 may include a number of collapsible and expandable datafields. For instance, the data fields may include a dose summary field3522, a patient's summary field 3524, and items field 3526, andingredients field 3528, a dose history field 3530. Furthermore, a dosepictures field 3532 may also be provided. For example, with furtherreference to FIG. 46, a dose pictures field 3532 is shown as populatedwith dose images 3576. The dose images 3576 may include product images3578 regarding a product to be included in the dose associated with theselected dose order 1320. The dose images 3576 may also include currentdose images 3580 regarding the current preparation of a dosecorresponding to the selected dose order 1320. Additionally, the doseimages 3576 may include prior dose images 3582 that may, for example,correspond to previous preparations of the dose associated with the doseorder record that may have been rejected by a pharmacist during reviewor the like.

With further reference to FIG. 35, the dose detail screen 3500 mayinclude a timestamp indication 3534 of the last update of the datadisplayed in the dose detail screen 3500. Furthermore, a clock value3536 regarding the next update to the dose detail screen 3500 may bedisplayed. Further still, a refresh button 3538 may be presented that,upon selection, updates the data displayed in the dose detail screen3500. Additionally, a print button 3540 is presented the user. As shownin FIG. 43, a print preview 3544 may be displayed upon selection of theprint button 3540. The print preview 3544 may allow for selectiveprinting of the data fields in the dose detail screen 3500 which areexpanded at the time of selection of the print button 3540. Furthermore,any dose pictures associated with the selected dose order 1320 includedin the dose pictures field 3532 may be displayed for printing in theprint preview 3544. The dose detail screen 3500 may also include adisposition/requeue link 3542 that may allow a user to modify the statusof the selected dose order 1320 from the dose detail screen 3500.

With reference to FIG. 36, the dose summary field 3522 is shown andexpanded configuration. In this regard, details regarding the dose suchas a time the dose was entered, a time the dose is to be administered orhas been administered, a time in which the dose expires, a preparationmode of the dose, a preparation procedure for the dose, a dosedescription, a dose overfill amount, a final volume for the dose,whether the dose is a dilution, whether the dose is a stock dose, alabel profile for the dose, a storage method for the dose, anadministration route for the dose, and am administration rate for thedose may be displayed in the dose summary field 3522 when expanded.Additionally, the patient summary field 3524 is shown in an expandedconfiguration FIG. 36. The patient summary data field 3524 may includepatient information such as a patient name, patient identifiers, apatient location, a nursing unit with which the patient is associated, apatient order ID number, or other information regarding the patient.Furthermore, clinical information regarding the patient may also bepresented such as a height of the patient, a body surface area thepatient, a weight of the patient, a basal energy expenditure of thepatient, or a birth date of the patient.

With additional reference to FIG. 37, the items field 3526 is shown inan expanded configuration. In this regard, items associated with theselected dose order record 1320 may be depicted. Additionally, theingredients field 3528 is shown as expanded in FIG. 37. In this regard,ingredients associated with the selected dose order record 1320 may bedisplayed including an amount, a concentration, and/or a volume of theingredient. Further still, the dose history field 3530 is also expandedin FIG. 37. In this regard, various scan events related to the selecteddose order record 1320 may be displayed in the dose history field 3530.For example, as shown in FIG. 37, a scanned event where the dose wasqueued may be shown including the entry date, entry time, user enteredthe dose, the workstation at which the dose was entered, and an eventdescription may be provided. With further reference to FIG. 49, anotherexample of a dose history field 3530 is displayed that includes alisting 3584 of previous scan events conducted relative to a selecteddose order. With return reference to FIG. 35, the summary tab 3512 mayalso include dose pictures 3532. In this regard, images associated withthe selected dose order record may be displayed in this field, such as,for example, current dose image 3580 depicted in FIG. 46.

In FIG. 38, the special notes tab 3514 has been selected. In turn, thedose detail screen 3500 may include a listing 3546 of special notes inrelation to the selected dose order 1320. FIG. 39 depicts the dosedetail screen 3500 upon selection of the attached documents tab 3516.Upon selection of the attached documents tab 3516, the dose detailscreen 3500 may display a listing 3548 of attached documents related tothe selected dose order 1320.

Furthermore, a document attachment field 3550 may be provided to allowuser to select a file for association with the selected dose order 1320by browsing profile to attach or may allow for a file to be dragged anddropped at the attachment field 3550 to associate an attachment with theselected dose order 1320. With further reference to FIG. 44, theattachment field 3550 is depicted with a listing 3566 of attached filesassociated with the selected dose order 1320. As may be appreciated, theattachments may include image files 3568, text files, portable documentformat (PDF) files 3570, or other relevant file formats as shown in FIG.44.

FIG. 40 shows the dose detail screen 3500 upon selection of the productsand procedures tab 3518. Upon selection of the products and procedurestab 3518, a number of data fields including a dose procedure field 3552,a dose preparation field 3554, a product procedure field 3556, and aproduct preparation field 3558 may be displayed. The dose procedurefield 3552 may provide a listing of procedures associated withpreparation of the dose associated with the selected dose order 1320.The dose preparation field 3554 may show a listing of steps in relationto dose procedures that may be required to be accomplished in order toprepare the dose associated with the selected dose order 1320. Forinstance, with further reference to FIG. 46, a dose preparation field3554 is shown as being populated with a listing 3574 of required stepsfor preparation of a selected order record 1320. In this regard, anidentifier of the step, a status of the completion of the step, a timeand date at which the step was completed, a capture type associated withthe step, a capture date and time associated with the capture type forthe step, and instruction text associated with the step may be displayedin the dose preparation field 3554.

With returned reference to FIG. 40, a product procedure field 3556 mayprovide procedures for preparation of products contained within the doseof the selected dose order 1320. In turn, the product preparation field3558 may display steps associated with the preparation of a product forinclusion when preparing a dose associated with the selected dose 1320.

FIG. 41 depicts the dose detail screen 3500 upon selection of theadditional information tab 3520. In this regard, a raw data field 3560may be presented that provides a user information regarding the rawlabel data (e.g., has received from a print stream or the like).Additionally, parsing errors field 3562 may present to the userinformation regarding any parsing errors occurred upon parsing theincoming dose order for generation of the selected dose order record1320. FIG. 42 depicts the other information field 3564 and expandedconfiguration. In this regard, additional information regarding theselected dose order record 1320 may be presented such as auxiliary data,barcode information, facility information, infusion rate information,this format information, dose administration frequency, as well as itemscontained within the selected dose order 1320.

FIG. 45 further depicts a clinical data field 3572 that may be displayedin a dose detail screen 3500. The clinical data field 3572 may include alisting of clinical ordered items 3574 in relation to a listing of items3576 included in the dose. The clinical data field 3572 may beparticularly useful in the field of a total parenteral nutrition (TPN)dose in which clinical ordered items 3574 may be used in relation to theitems contained in the order 3576 to easily compare the requested doseingredients 3574 with a compound a result listing 3572 to ensure thatthe correct items are included in the dose.

With return reference to FIG. 8, selection of the place on hold button1324 may result in the selected dose order 1320 being placed on holdstatus. Selection of the remove from hold button 1326 may result in aselected dose order record 1320 that is currently a hold status beingremoved from hold status. It may be appreciated from FIG. 8, theselected dose order 1320 and the particular embodiment shown is not onhold, therefore the place on hold button 1324 may be enabled while theremove from hold button 1326 may be disabled. In contrast, if a selecteddose order 1320 was a dose order with an on hold status, the place onhold button 1324 may be disabled and the removed from hold button 1326may be enabled. Selection of the discontinue button 1328 may result inthe selected dose order 1320 being discontinued (i.e., the status of theselected dose order 1320 may be changed to a discontinued status).Selection of the modify button 1330 may result in display of a dosemodification screen 1348 that allows for one or more portions of doseorder metadata to be modified as shown in FIG. 9.

Furthermore, the availability of a button for performing an operationrelative to a dose order may be at least partially based on a level ofauthorization of a user. In turn, the enablement of one or more of thebuttons that provide management functionality relative to the doseorders appearing in the dose order record listing 1312 may be based uponpermission data as described above. As such, for example, a user mayhave the ability to place a dose order on hold or remove a dose orderfrom hold using the place on hold button 1324 or remove from hold button1326, but not have sufficient authorization to modify a dose order usingthe modify button 1330. Further still, a user may have authorization toview a dose order record listing 1312 alone without any authorization tomodify a dose in any regard. Each of these permission identificationsmay be provided in permission data relative to the user.

With continued reference to FIG. 9, the dose modification screen 1348may be displayed upon selection of the modify button 1330 with respectto a selected dose order 1320. The dose modification screen 1348 mayinclude the dose order record listing 1350 and a dose modification field1352. The dose modification field 1352 may include one or more fieldsthat allow for modification of one or more dose order record data fieldsassociated with the selected dose order 1320. For example, the dosepriority, dose location, administration time of the dose, nursing unitto which the patient for the dose belongs, or other parameters may bemodified for the selected dose order record 1320. The dose modificationfield 1352 may also provide a field to accept a reason for themodification of the selected dose order record 1320. Providing a reasonfor modification of the dose may be required field that must be selectedby user prior to allowing the dose order record to be modified. Thereason may be selected from a drop-down field that may include aplurality of predefined reasons that may be selectable by a user.Additionally or alternatively, the user may enter a reason for themodification using free-form text entry in the other reason box.Furthermore, depending upon the authorization level of the user, theother reason provided by the user may be included for later selectionand the reason drop-down list.

With further reference to FIG. 10, the dose order management screen 1310is shown when the verify tab 1316 is selected. Upon selection of theverify 1316, doses that have been prepared and are waiting pharmacistverification may be displayed. Additional aspects related to pharmacistverification are described in greater detail below. Furthermore, FIG. 10depicts the dose order management screen 1310 upon selection of await/hold secondary filter from the secondary filter list 1318. In thisregard, the dose order record listing 1312 may be divided based upon adose order record status of having a hold or wait status. Also shown inFIG. 10, a plurality of queue filters 1336 may also be provided. Thequeue filters 1336 may be configurable by a user and may allow forcustomization of filters to be provided. In this regard, the queuefilters 1336 may include customizable parameter selection such that afiltered dose order record listing 1312 may be based upon any desiredmetadata for one or more dose order record data fields associated withthe dose order records. That is, the queue filters 1336 may query anyone or more of the dose order record data fields associated with each ofthe dose order records in return only those dose order records thatmatch a query.

With further reference to FIG. 11, a further embodiment of the dosemanagement screen 1310 is depicted. As shown in FIG. 11, the dose orderrecord listing 1312 may be configurable to depict categorization of doseorder records within the dose order record listing 1312. For example,user interface elements may allow for a column heading such as, forexample, the patient name 1338 as shown in FIG. 11 to be dragged anddropped to a categorization bar 1340. Upon selection of the columnheading 1338 for use in the categorization bar 1340, the correspondingcolumn heading 1338 may appear in the categorization bar 1340. In turn,the dose order record listing 1312 may be configured to display doseorder records according to category selected based upon the columnheading 1338 selected. For example, shown in FIG. 11, the patient namecolumn heading 1338 has been selected for use in the categorization bar1340. In turn, the dose order record listing 1312 may be categorizedaccording to patient name. Thus, the dose order record listing 1312 mayinclude category headings 1342 within the dose order record listing 1312such that associated dose order records 1344 corresponding to thecategory heading 1342 are presented. As may be appreciated, eachcategory heading 1342 may be expanded or collapsed such that theassociated dose order records 1344 for each category heading 1342 may beshown or hidden. It may be further appreciated the multiple categoryheadings 1338 may be dragged and dropped to the categorization bar 1340.As such, the categorization within the dose order record listing 1312may include a hierarchical listing such that a plurality ofhierarchically displayed category headings 1342 may be provided in thedose order record listing 1312.

FIG. 11 also displays a column layout selection 1346 that allows fordifferent column headings 1338 to be shown and/or hidden in the doseorder record listing 1312. The column layout selection 1346 also allowsfor arrangement of the various column headings 1338. In this regard, thecolumn layout selection 1346 may allow for user customization. In turn,the user may arrange the dose order record listing 1312 as desiredincluding selection and/or arrangement of various column heads,categorization and/or filter results. In turn, once users authorized inthe login screen 1302, the last used dose order record listing 1312configuration or a default dose order record listing 1312 configurationany presented to the user.

Rules may also be used to otherwise assist in management of the doseorder records in the dose order queue. For example, the local server 330may also include or be in operative communication with a dose logicengine (“DLE”). The DLE may be operative to evaluate dose order recordsbased on one or more portions of dose metadata stored in correspondingdose order record data fields. In this regard, anyone or more theportions of dose order metadata as described above may be utilized in arule implemented by the DLE. Furthermore, conditions for execution ofrules executed by the DLE may be established such that the rule may beperformed at one or more times on dose order records. For example, oneor more rules may be executed on a dose order record by the DLE when thedose order record is initially populated in the dose order queue and/orupon a subsequent condition being satisfied such as a change in statusof the dose order record or the like. In any regard, a rule executed bythe DLE may include scrutinizing one or more portions of dose metadatain view of a rule. For example, Boolean searching or the like may beutilized to identify whether a rule is to be applied to the dose orderrecord based on the occurrence of a selected parameter in the dose ordermetadata. Upon determining that a rule applies to a dose order record,an operation may be associated with the rule that is in turn executed ondose order records determined to be applicable to the rule. Theoperation may be utilized to manage and/or modify the dose order recordidentified by the rule. For example, the operations may include changinga status of the dose order, modifying metadata of the dose order, orother appropriate operation with respect order record or metadataassociated with the dose order record. Two such examples of operationsthat may perform by the DLE include identifying duplicate orders and/ordiscontinued orders.

In a duplicate order detection rule, the DLE may be operative to reviewa first dose order record in view of other dose order records within thedose order queue to determine if the first dose order record correspondsto a potential duplicate dose order. In this regard, the DLE mayevaluate the metadata regarding the first dose order record to determineif other ones of the dose order records within the dose order queuematch the identified metadata regarding the dose order to apredetermined correspondence. The predetermined correspondence may beselectable by a user of the management tool 1300. It may be appreciatedthat the matching of the metadata between the dose order records beingreviewed and the other dose order records in the queue may notnecessarily need to be identical. For example, the rule may be writtensuch that if selected ones of the metadata fields are identical betweenthe first dose order record being reviewed and the other dose orderrecords in the dose order queue, the dose order record being reviewedmay be flagged is a potential duplicate order. Such a rule may beapplied to the first dose order record when the record is initiallypopulated the dose order queue.

In this regard, with further reference to FIG. 12, may be appreciatedthat the dose order records that have been identified as a potentialduplicate order may be sorted and presented to a user. In this regard,the dose order management screen 1310 may include a secondary filter forpresenting suspect duplicates in the dose order record listing 1312. Inthis regard, the dose order record listing 1312 may be populated withsuspected duplicates. In this regard, the dose order record listing 1312may present a user in an original dose order record 1362 that isassociated with one or more suspected duplicates 1364 based on exceedinga predetermined correspondence between the metadata of the suspectedduplicates 1364 the original dose order record 1362.

Accordingly, upon selection of the suspected duplicate 1364, number ofoperation buttons may be enabled. For example, the user may selectdetail button 1366 to be presented with additional details regarding thesuspected duplicate order 1364 and/or the original order 1362. In turn,the user may determine suspected duplicate 1364 may not in fact be aduplicate order, but rather be a valid order the should proceedpreparation. In this regard, the user may select the ignore button 1368to indicate that the suspected duplicate 1364 is not in fact a duplicateof the original order 1362. In contrast, should the user determine thatthe duplicate order 1364 is in fact duplicate of the original order1362, the user may select the discontinue button 1370 to discontinue theduplicate order 1364 such that the duplicate order may be removed fromthe dose order queue. Upon selection of either the discontinue button1370 or the ignore button 1368, the user may be present the dialog boxthat may require the user to identify the reason for the discontinuationor ignoring of the suspected duplicate status of the dose order.

Additionally, it may be recognized that the DLE may process incomingdose orders to determine if the order corresponds to a discontinuationof an order. That is, a common practice when processing dose orders isto indicate a discontinuation of a first order by subsequently sending acorresponding order to the first order at a later time with adiscontinue status for the subsequently provided order. In priorapproaches, the receipt of such a discontinued order may simply resultin printing a label with the dose order details and a discontinuationstatus. This would in turn require a user to go through the printed doseorder labels to locate the original dose order that was referenced inthe discontinued dose order in order to replace the original dose orderon a discontinued status. The DLE may be utilized to automate thisprocess in the context of the dose order queue stored by the localserver 330 by identifying receipt of a dose order in the dose orderqueue that contains a discontinued status and automatically matching thediscontinued dose to one or more existing dose order records. Thus,receipt of a dose order with a discontinued status may trigger the DLEto perform a query of the dose order queue to identify correspondingones of the dose orders in the dose order queue that exceed apredetermined correspondence to the discontinued dose order. Forexample, one or more overlapping or identical pieces of metadata betweenthe discontinue dose order and the identified discontinued order in thedose order queue may be determined. The predetermined correspondence maybe customizable by a user. In any regard, upon identification of a doseorder record from the dose order queue that corresponds to a receiveddiscontinued dose order, the original dose order may automaticallychange the status of the one or more identified dose order records to adiscontinued status.

The execution of a discontinued dose rule by the DLE may also at leastpartially be based upon the status of the one or more dose order recordsfrom the dose order queue that are identified as discontinued doses atthe time the dose order records are identified. For example, in oneexample, the dose order for the dose order record identified as adiscontinued dose may not yet have been prepared. In this regard, theDLE may simply change the status the dose order record to discontinuedand remove the dose order record from the dose order queue such that thediscontinued dose order record is not prepared. In contrast, theidentified discontinued dose order record may have been prepared andverified and be in sort awaiting dispatch from the pharmacy. In thisregard, the status of the dose order may be modified to discontinued andany resulting dose that was prepared for the dose order record may bechanged from a dose to a product. That is, the dose order system mayprint a work in progress label or other identifier that allows theprepared dose to be moved to pharmacy stock for later use (e.g., tofulfill a later dose order received at the pharmacy). The modificationof a dose to a produce may also occur in the case where a dose has beenprepared and not yet verified. In this regard, the pharmacist thatperforms the verification may be presented with the status of the dosebeing discontinued.

In addition to the dose order record management functions related to thedose order records described above, the pharmacy workflow managementapplication 114 may further be operative to provide dose order recordsto a workstation for the purpose of fulfilling or preparing the doseorder record at the workstation. Any number of different workstationscan be part of the system. For example, FIG. 2 shows a flowhoodworkstation A 500, a flowhood workstation B 510, and a chemo workstation520. However, other workstations may be provided without limitation. Forinstance, those skilled in the art will recognize a number of differentworkstations that are often utilized in the pharmacy environment. Suchworkstations may include laminar flow hoods, biohazard cabinets, orother particularized workstations used in the preparation of specificdoses. However, other workstations may also be included that do notactually prepare doses, but may be used for pharmacy management such assupervisory terminals (e.g. that perform web-based system management,query reporting, etc.), situation boards that display system status orthe like, pharmacist review stations, or other appropriate workstationsin operative communication with the local server 330 to communicate doseorder record and associated metadata.

In any regard, the local server 330 may be operative to communicate witha workstation to provide information related to the dose order recordthereto. For example, in order to prepare a medication dose at one ofthe workstations, data regarding a corresponding medication dose orderrecord may be sent by the local server 330 to the appropriateworkstation. As may be appreciated, the various workstations may beparticularly suited for particular type of medication dose to beprepared. For instance, a dose of chemotherapy to be administered to apatient may be provided to the chemo workstation 520, whereas anothertype of dose may be prepared at another workstation within the localsystem 110.

With returned reference to FIG. 4, information related to dose orderrecords may be forwarded to client applications executing on one or moreworkstations located within the pharmacy, hospital, or elsewhere. Theworkstation client application or technician can manage the various opentasks (e.g., orders to fill) by interacting with the workstation inorder to follow a protocol or “recipe” mandated for a particular doseorder or batch of orders, as indicated a block 440. The dose orders areprepared as doses at the workstation with the benefit of documentationsupport as indicated a block 430. The documentation support is providedto the technician to guide preparation and better ensure the doses areprepared in accordance with established protocols and policies. Asdescribed further below, the intermediate steps in the preparation ofeach dose order are subject to data capture to permit post preparationreview of the steps taken to prepare each dose.

Returning to the dose preparation workflow and documentation support 430and management of scheduled tasks by the workstation 440 depicted inFIG. 4, an exemplary method performed in relation to these schematicallydepicted tasks as shown in FIG. 13. The order filling processingcommences at step 530 at which it is determined whether there anyone tofill dose order records in the database.

If unfulfilled dose order records are in the database, unfulfilled doseorder records are retrieved at step 540. At decision 541, it may bedetermined whether a dose previously prepared and stored which wouldsatisfy the dose order. For disclosure of assist in the prepared doseorders in anticipation of need for such orders, see U.S. applicationSer. No. 11/844,135, filed Aug. 23, 2007, entitled “AutomatedCentralized Preparation of Medications in Anticipation of Use,” which isco-owned with the present application and hereby incorporated byreference in its entirety. If no such dose exists, the dose order may beposted to the dose order queue at each workstation and may also beposted to the situation board 400 at step 542. Additionally, the doseorder record may be updated so that a status of the dose order recordsindicated as “pending” to signify the dose order is ready to beprepared. Optionally, the requirements for filling the dose order areretrieved and used to post the dose order to the dose order queues onlythose workstations that are suitable for handling such dose order. Inthis way, individual workstations may have a tailored queue of pendingdose orders. In another arrangement, such tailored queues are providedto the individual workstations with the operator such workstation canexpand the presentation to see other disorders in the queue even if notsuitable for handling of the operators given workstation.

With returned reference to FIG. 13, at step 542, the drug order queue isgenerated and optionally one or more dose orders can be assigned to aparticular workstation based on one or more rules that govern thedistribution of dose orders to a particular workstation. The system maybe configured so that the dose orders must be “pulled” from the doseorder queue. In other words, an affirmative step may be required for thedose order to be assigned to particular workstation. For example, asdiscussed above, an operator at a given workstation may review the doseorder queue and then select the dose orders that will be fulfilled atthe given workstation (e.g., by using a touch screen display), at whichtime these orders are effectively assigned to workstation and areremoved from the dose order queue.

In some instances the workstation is in the form of an automated deviceand therefore, the automated device has a selection module comprisingcode to automatically select those dose orders in the queue that can befulfilled by the workstation. The selection can take into account numberof different rules including the number of pending dose orders at thisworkstation, the availability of different drugs, etc. The automateddevice communicates with the local server 330 and selects and pulls doseorder for filling.

However, even when the system is configured to operate in such a pullmode, the individual dose orders can be preassigned in the event that adose order can only be fulfilled by a specific workstation, in whichcase the application 114 may recognize this fact and identifies that theparticular dose order is intended for delivery to a particularworkstation. For example, if the dose order that is received andprocessed step 541 is the type that can only be fulfilled by specificworkstation (e.g., chemotherapy workstation), the dose order will beidentified as such on the dose order queue in the workstation type isqualified for receiving and fulfilling the dose order can be notified(e.g., the chemo workstation 520 as shown in FIG. 2). Similarly, thetype of dose order can be identified as a manual fill dose order on thesituation board in one or more manual workstations can be alerted or tosimply include the dose order on screen.

In another application, the system may be configured to “push” doseorders to the individual workstations. In this regard, the local server330 may select which workstation is best capable of handling incomingdose order and assign the dose order to that workstation. Workstationmay then be sent to the workstation fulfillment of the order. In thisregard, the “pushing” dose orders to the individual workstations may bebased on a multitude of factors including, for example, the type ofworkstation, the backlog of dose orders, the types of drugs located at agiven workstation, the technician logged in at a given workstation, orother factors.

Furthermore, the application 114 can analyze the supplies necessary tofulfill the order. The list of required supplies may be compared to aninventory of supplies and their availability, optionally broken down byhospital, pharmacy location, or workstation. If there are insufficientsupplies, additional supplies may be automatically order the relocationof supplies from one workstation to another may be ordered such that atleast one workstation will have the necessary supplies to fulfill thedose order.

In an embodiment, a rule-based management of dose orders (e.g., by wayof the DLE discussed above) may facilitate automatically assigning adose order based on the preparation mode for the dose order. Forexample, the dose order may be evaluated with respect to at least oneportion of dose order metadata stored in a dose order record data fieldassociated with the dose order record. This evaluation may be performedupon population of the dose orders to the dose order queue. In turn, theevaluation may result in the preparation mode being assigned to anorder. In turn, the user may be free of selecting the preparation modeassociate of the dose order record, rather the preparation mode may beassigned automatically in response to the evaluation of the at least oneportion of dose order metadata stored in the dose order record datafield. The preparation mode assigned the dose order may be used, forexample, to generate and/or select an appropriate preparation procedurefor that dose order. Such preparation procedure may in turn be presentedto a user when preparing the dose. As the preparation mode may beautomatically attributed to the dose order based on application of arule to the dose order, the user may not be required to select thepreparation mode for the dose order. In turn, the dose order may berouted to an appropriate workstation where the user may be presentedwith the preparation procedure at least partially based on theautomatically assigned preparation mode that is been associated with thedose order record by the system. Furthermore, dose orders that have thesame preparation mode may also be grouped together into a micro batch ina queue view list.

In this regard, the pharmacy workflow management application 114 mayallow for a dose order record to be communicated to a workstation forpreparing a dose associated with the dose order record. As may beappreciated, the protocol or “recipe” corresponding to the dose orderrecord may be provided to a technician at the workstation for use inpreparing the dose. During the preparation of the dose, the technicianmay scan, enter, capture, or otherwise generate or record dose ordermetadata corresponding to the dose order being prepared. At least aportion of this information collected by the technician duringpreparation of the dose may be utilized to allow for a pharmacist reviewof the preparation of the dose as described in greater below.

With returned reference to FIG. 13, if the dose-order is one determinedto be suited for manual preparation, then the process flow branches toblock 560. At block 560, protocol information is retrieved. This isbecause, before the dose order record is dispatched to a manualworkstation for action by the operator, additional information isprovided to facilitate the manual fulfillment of the dose order at theselected workstation. This can be based on the determination that manualpreparation is required and the assumption that providing additionalinformation can improve safety, efficiency, and precision duringfulfillment of the dose order. The management module can associate theadditional information with the dose order record. For example, at step560 the medication and form of dose (e.g., syringe, IV, oral dose etc.)specified by the dose order record can be examined so as to determinethe protocol by which the dose of that medication should be prepared.The protocol can specify the steps (e.g., sanitization anddocumentation) that must be taken during preparation to comply with Foodand Drug Administration regulations or any other governing proceduresregarding the conduct of the pharmacy. Furthermore, the protocolassociated with the dose order at steps 560 and 562, preferably isinteractive in guiding the operator through the fulfillment process toachieve the same level of accuracy and dose safety which is typicallyassociated with the automation. For example, the protocol can requirethe operator's input including logging of events at critical stages ofthe dose preparation process (e.g., requiring the operator to scaninformation related to the source drug containers).

The additional information (i.e., protocol) can be associated with thedose order record at step 562 for presentation to the operator. Theassociation can be accomplished by attaching the protocol file to thedose order record, or otherwise communicating it electronically to theworkstation selected for handling that dose order, or by printing a copyof the protocol to include with a printed order for the dose. In apaperless environment, the protocol is preferably displayed along withthe display of the order or can appear as a hyperlink or call-up dialogbox from within the order display at the workstation.

Referring briefly to FIG. 14, one exemplary screen 600 is illustratedthat lists a number of steps generally indicated at 610 that arerequired to be performed to successfully prepare a medication productthat is used to prepare a dose that is part of a dose order. On the leftside of the screen, the drug to be prepared is clearly identified at620, in this case Cefazolin 1 g (Apoth). This screen is an interactivescreen in that the user can simply highlight different areas either toreceive more information or to enter information. For example, there isa Detail button 622 near the drug identification and if additionalinformation is needed concerning this particular drug order, the usercan simply highlight this particular button (as by “clicking” the box).

On the right side of the screen are processing steps 610 that must beundertaken in order to prepare the requested dose. For example, a banner612 indicates again the drug being produced is Cefazolin 1 g (Apoth) andbelow this banner there are a number of steps 610 that must be performedin order to produce the correct dose (drug product). The illustratedscreen shows a first step 614 of printing and applying a product label.The label is printed by simply pressing the button 616 that is labeled“Print Label”. As soon as the label is printed, the user is prompted tomove on to the next step 618 which is a step of scanning the product toverify that the proper product is present at the workstation.Conventionally scanning equipment can be used to scan (e.g., a barcode)the product and then the user is prompted to enter the Product LotNumber in a box 620 that is provided and the user then enters theProduct Expiration Date in another box 622. All this inputtedinformation is used to confirm that the correct product (drug) ispresent and is being used in the preparation of the Cefazolin 1 g dose.In this regard, it may be appreciated pharmacy workflow managementapplication 114 may require a previous step to be completed prior tomoving to a subsequent step. Performance of some steps may includepositive capture of information related to the dose being prepared. Inturn, the sequence of the protocol presented for a dose may bedocumented and explicit steps in relation thereto may be required priorto progressing in the sequence.

In another aspect of the present invention, other identifyinginformation can be used to assist in determining that the correct drugis present at the workstation and is suitable for use in fulfilling apending drug order. More specifically, the Drug Listing Act of 1972requires registered drug establishments to provide the Food and DrugAdministration (FDA) with a current list of all drugs manufactured,prepared, propagated, compounded, or processed by it for commercialdistribution. The National Drug Code (NDC) is a universal productidentifier used in the United States for drugs intended for human use.The FDA inputs the full NDC number and the information submitted as partof the listing process into a database known as the Drug Registrationand Listing System (DRLS). The information submitted as part of thelisting process, the NDC number, DRLS, and the NDC Directory are used inthe implementation and enforcement of the Act. In turn, the NDC for adrug may be recorded during the preparation of a dose. A formulary ofthe pharmacy workflow management application 114 may be cross-referencedto determine if the NDC received during preparation corresponds to adrug appropriate for the dose being prepared. If the NDC is appropriateas determined by reference to the formulary, the user may be allowed tosequence to the next step in the process. If the NDC does not match, theoperator may not be allowed to progress and the fact that in incorrectNDC was provided may be noted. It will also be appreciated that some ofthis information can be inputted using a reader devices, such as abarcode reader, etc.

Dose order records stored in the local database can be ordered orarranged and displayed in the dose order queue and/or at the situationboard in accordance with a rule base that operates on the database withone or more rules. The rules may be at least partially based on doseorder metadata populating one or more dose order record data fields. Forexample, one rule can be to optimize fulfillment of the orders. Thus,like dose orders (e.g., dose orders with similar drug components asreflected in the dose order metadata) can be processed at the sameworkstation one after another and hence faster because there is lesscross-contamination and medication changes (i.e., retrieval andstorage). Thus, dose orders can be grouped by type or medication, suchthat dose records requiring the same medication or with no risk ofcross-contamination can be processed in order by the same machine, orset of machines. In this regard, the rules are configured to sort thedose-orders by type or medication. Alternatively, dose order records canbe prioritized by urgency (e.g., “First Doses” or “STAT”). For example,if a doctor urgently needs a specific medication, the data streamidentifying the dose can include information indicating its urgency, andthe dose order record can include such urgency information. Thus, therule in this instance operates to re-sort an urgent order to near thefront of the queue, or have that order identified (e.g., flagged) asurgent for immediate or expedited fulfillment. Through this or a similarmechanism, the next unfulfilled dose order retrieved at step 140 can bearranged in the queue to optimize throughput or to satisfy otherrule-based priorities. Alternatively and as described above, urgentorders can simply be highlighted and/or labeled as such in the drugorder queue presented at the workstation.

The workstation can include various tools and monitoring equipment toassist and perform quality control during the manual preparation of thedose order. Such tools and monitoring equipment can include barcodescanners, digital cameras, scales, hydrometers, spectrometers, and othertools that can be used to verify the properties of a substance. Forexample, a computer monitor at the workstation can prompt the operatorto take certain measurements of the dose order being prepared and inputthe results of those measurements. Failure to input a measurement withinan acceptable range can result in the system automatically rejecting thepreparation. Furthermore, to prevent operator fraud, the system canprompt the operator to place the preparation on a scale, or withinanother instrument, that automates the measurement, thereby reducing theopportunity for the operator to intentionally or unintentionally deceivethe system. In this regard, it should be appreciated that the protocolpresented to the used at block 562 is preferably coded to capture theprogress made toward dose fulfillment. Thus, steps taken in completingthe protocol or recipe are preferably coupled with specific operatorinput such as photographing a drug vial, weighing a syringe, and thelike, with the inputs being captured and included in a data record thatcan be forwarded to the pharmacist for review and approval. The datarecord can be a record storable in the Ensemble database that is used ina preferred embodiment of the invention.

In accordance with the present invention and as previously mentioned,the present system includes means, such as readers and the like, whichallow a particular drug to be identified at step 618 and compared to adatabase to ensure that the identified drug is the drug which is beingrequested is the same drug which has been identified at a particularlocation (station) of the present system. Since the NDC includes productcode information, such as the specific strength, dosage form andformulation, it can be used in drug identification step 618 of thepresent system. It will also be appreciated that the NDC number canprovide a means for redundantly confirming the identification of thedrug being used at the workstation to prepare the requested drug order.In other words, other identifying information that is printed orotherwise present on the drug product can be read and then the NDCnumber can be read and the two compared as part of an integrity check toensure that the correct drug product is present at the workstation.

The next step 624 involves scanning the diluent that is used in thereconstitution process. Once again, conventional scanning or imagingtechniques can be used to identify and confirm whether the correctdiluent is being used in the reconstitution process. The step 626involves acquiring the diluent for the reconstitution and thenconfirming its proper identity and the user can indicate that the stephas been completed by pressing the button labeled “Done”. The next step628 can involve capturing the image of the diluent using conventionallytechniques (e.g., a camera) and additional steps that can be performedare capturing the image of the completed vial 630 and scanning a dose tobegin preparation of the individual dose 632. All of the informationthat is gathered in each of the steps is stored in the local database,preferably in the same record as or in association with the particulardrug order being filled.

At any point, if a task performed in one of the steps is not verified asbeing correct, the operator is prevented from going onto the next stepand the dose is not prepared.

Also, with brief reference to FIG. 15, a sample screen 700 showsexemplary steps that are displayed to the operator to assist theoperator in preparing a specific dose of medication. On the left side ofthe screen, a “Selected Products Information” section 710 is providedand lists the drug product that is being prepared. In this example, thedrug product is Cefazolin 1 g (Apoth). On the right side of the screenis information 720 that relates to the current dose that is beingprepared for a specific patient. For example, the patient's name (e.g.,Karen Mirabelli) is clearly identified along with any identifyingpatient information (a patient number). The dose information alsoincludes a final volume of the dose (e.g., 1 ml) and administrationinformation is provided, such as a date and time (e.g., 8/7/08 17:04)when the dose is to be administered. The type of dose (e.g., STAT) canalso be listed to alert the operator to any special processinginformation (e.g., the dose should be processed in an urgent manner).

The screen of FIG. 15 lists a number of steps 730 that are to beperformed by the user to prepare the dose and fulfill the dose order.For example, one step may be the step of applying a label to the doseand once this task is performed, the user can indicate so by pressing abutton that is labeled “Done”. Another step can be to acquire the dosevolume from the product and once this task is performed, the user canindicate so by pressing a button that is labeled “Done”. Other stepsthat are to be performed and verified are capturing the image of theproduct dose transfer; capturing the image of the completed dose; andscanning the barcode label on the completed dose. Each of these stepsmust be verified as being properly completed before the user cancontinue with the other steps of the dose preparation process.

The NDC information also contains formulary information and this can beused at the workstation as the drug is being prepared in accordance withthe steps shown and described with reference to FIG. 15. In particular,this information can be used as part of an integrity check (drugverification process) to ensure that the drug is being preparedproperly.

As mentioned above, if it is determined at step 550 that the dose orderrecord is suitable for automated handling, it will be queued at anappropriate automated workstation. Queuing the dose order record at aworkstation presents a further opportunity to optimize the distributionof orders within the pharmacy. For example, it may not be feasible todetermine at step 140 an optimal organization of dose order records toensure that dose order records requiring similar medications are queuedat the same workstation. Thus, at step 570, a particular dose order canbe queued at an automated workstation that is known to be processing thesame medication, or to any workstation at which a dose order involvingthe same medication was just queued (e.g., a workstation to which thedose order and protocol are provided at block 560. Re-ordering andqueuing of dose orders can be very flexible if the urgency of the doseorder is very low. For example, the dose orders can be queued in a lessthan optimal order with respect to time, but more efficient with respectto medication changes and cleanings to prevent cross-contamination.Optionally, the current workload and/or work distribution of dose ordersto workstations can be tracked or monitored and presented to a user(e.g., presented on a centralized display) for management andperformance monitoring.

Once the workstation fulfills the dose order, the status of the doseorder record can be changed to indicate that it has been processed atstep 580. The status change can be received by the pharmacy workflowmanagement application 114 as an acknowledgement that the drug dosageform has been prepared, or as a “processed-order” status, and this canfurther result in an update to the dose order record, the inventoryrecord, or both concerning any drug dosage forms that have been preparedbut not yet delivered. Additionally, data concerning the assignment ofthe dose order to the selected workstation and the completion of thedose order can be logged in the database. Logging information concerningwhich workstation processed the dose order into the database (e.g., thelocal database 330), as indicated at step 590, enables complete trackingof both the dose-order processing steps and tracking of the prepareddose itself from its entry as data into the pharmacy system to itsdelivery to the patient. Accordingly, at step 590, the information canbe logged into the local database 112.

The present system therefore provides a composite workflow applicationthat can layer on top of a hospital's existing pharmacy informationsystem 320, without requiring any changes to that system, in order tomanage the production of IV doses (and other doses) in the pharmacy,track dose delivery from the pharmacy, prevent medication errors causedby incorrect dose preparation, capture detailed history of dosepreparation (including images), and serve as a gateway to automationsystems throughout the pharmacy, such as carousels, compounders, and IVrobots.

Accordingly, the pharmacy workflow management application 114 may allowfor a pharmacist review of a dose prior to the dose being distributedfrom the pharmacy is depicted in the pharmacy dose verification andapproval step 450 of FIG. 4. In traditional approaches to pharmacistreview, a pharmacist would often have to enter the pharmacy to verifywork performed by a pharmacy technician. Oftentimes, such preparationenvironments comprise clean rooms such that the pharmacist might have togo through an extensive gowning process in order to access the area inwhich the dose is being prepared. In contrast, given the centralizedstorage of dose order metadata facilitated by the pharmacy workflowmanagement application 114, a pharmacist may utilize a remote accessterminal 314 or a client at the local system 110 that is external to thepharmacy, but still within the local system 110 to access, review, andapprove or deny doses prepared by technicians.

Accordingly, the pharmacy workflow management application 114 mayprovide for remote inspection of prepared doses, thus facilitating thepractice of telepharmacy, by which a pharmacist can inspect the dosepreparation from any location inside the hospital or elsewhere so thedose is released more quickly and efficiently from the pharmacy.Accordingly, dose inspection/verification may be performed by apharmacist from any location using the portal the present invention.Dose order record metadata stored at the local server 330 may bepresented to the pharmacist for inspection and approval. The portal maybe provided through a conventional web browser, optionally with the useof a plug-in or other active code that provides for review of the datapresented such as, for example, magnification, rotation, contrastadjustments, and other adjustments to an image to facilitate interview.

In turn, a pharmacist may be presented with images associated with thepreparation of the dose. The pharmacist can not only look at images ofthe final product, including the product label, and other relatedproduct information, such as a barcode information, but also, thepharmacist can review information and images that obtain the particularsteps in the overall drug preparation process. For example, during adrug reconstitution process, the operator may step through the drugpreparation as described above such that the operator must confirm eachstep is successfully completed prior to moving to the next step. One ofthe steps in the preparation of the dose may be the selection of aparticular drug vial. The selection of the drug while may be capturedusing the camera to produce an image that may be later viewed by thepharmacist. Additionally or alternatively, a scanning event during whichthe operator identifies the drug vial being used by scanning a barcodeon the drug vial may also produce data that is reviewable by thepharmacist. The pharmacist can view each or many of the steps are takenin order to confirm that steps properly completed in the protocol toprepare the preparation and thus, confirmed the dose is properlyprepared. The remote verification facilitated by the pharmacy workflowmanagement application 114 provides a superior and more complete way ofinspecting and verifying a dose prior to releasing the dose to thepatient because the pharmacist may be able to visually inspect multipleimages and/or data obtained during the steps of preparing of the drug toconfirm that the steps are carried out properly, and thus, ultimatelyconclude whether the dose order is properly prepared and should bereleased the patient. In contrast, traditional approaches may rely upona pharmacist discussing with the technician the steps taken to prepareddose without any way to actually verify the steps performed. Thisimproved verification may be important in many circumstances, includingwhen the constituent components of the final dose include more than oneclear fluid such that a visual inspection of the final dose alone cannotprovide a basis for the pharmacist to confirm the accuracy of the dose.Thus, benefit results from the capture and review steps, regardless ofwhether the pharmacist is on-site or remotely situated.

FIGS. 16 and 17 show an embodiment of a user interface for depictingvarious images that can be selected by a pharmacist in order to view afinal dose order, in this case a syringe filled with medication.Different angles and different views are available to the pharmacist, aswell as information that has been captured in other ways such as byscanning or weighing steps, if called for in the recipe at theworkstation that prepared the final dose being inspected.

Preferably, the local server 330 includes web services or acommunication module that enables the data records associated with thedose order and its production to be viewed through a conventionalweb-browser program. As such, the pharmacist no longer has to bephysically within the pharmacy to inspect and verify dose orders andultimately either approve and release the dose order or reject the doseorder. The opportunities that this system presents are varied and great.For example, a number of pharmacies can subscribe to a service wherepharmacists inspect and verify dose orders from a remote location,either all the time or after the close of normal business hours. Inaddition, when the drug orders are prepared by automated drugpreparation devices as opposed to pharmacy clerks, the inspection andverification process can be outsourced to one or more pharmacists whoreview and verify the dose orders.

In addition, a panel of pharmacists can, at one or more remotelocations, review the dose orders that have been prepared by a number ofdifferent workstations (both automated and manual), regardless of thelocation of such workstations. Each pharmacist can review all of thedigital records and stored information as described above as part of theinspection process and then can approve the dose order for release ifthe pharmacist concludes that the dose order was properly prepared. Theapproval process can comprise messages communicated through the portal,e.g., a web-browser application such that the pharmacist simply logsinto the system and approves particular orders by mouse-clicks,keystrokes, and other conventional inputs that are forwarded to thelocal server that was the source of that particular dose order. Aconventional login process with password and optionally furtheruser-authentication ensures that the pharmacist's identity is verifiedbefore providing access to the pharmacist to any dose order information.The system can be designed so that for each dose order, the pharmacistmust enter a unique identifier, such as a password, in order to releasethe drug. The date and time of the inspection and release or rejectionof the dose order is also logged. Optionally, this information can beassociated with the dose order record so that the approval stage issaved together with the processing steps to fill the dose order. In thismanner, a record of which pharmacist has approved a particular doseorder can be saved.

It will be appreciated that an entity can be formed in whichpharmacist-members span the world in different time zones so as to havea pharmacist available regardless of the time of day to inspect andrelease or reject a particular dose order. The pharmacists can thus bepart of an organization or a corporation that offers this service todifferent pharmacies across the globe. To accommodate differentlanguages, the software can be configured to offer the dose orderinformation in different languages, which can be selected in a pull downmenu on a screen, such as a login screen.

With further reference to FIG. 18, the dose order management tool 1300may allow for a user to view and/or modify who has control over a doseorder undergoing verification. For example, when a user selects a doseorder record that has been prepared in order to verify the dose order,the dose order status may be changed to “at verification” or “claimed”to indicate that the dose is being verified by a user. However, undercertain scenarios, the user may become distracted, be called away fromthe terminal at which verification is being performed, or otherwise bedisposed such that the dose being verified remains in the claimed statuswithout further action being taken with respect to the dose order. Itmay be beneficial to allow for another user to obtain control of thedose order record being verified such as for example, when a dose orderassociated with the verified dose order record is approachingadministration time or if the dose order has a STAT priority or thelike. Accordingly, with respect to FIG. 18, when tab 1316 is selected todisplay dose is awaiting verification, a secondary filter 1318associated with doses being verified may be displayed to present a doseorder record listing 1312 populated with dose order records with aclaimed status. That is, upon selection of the being verified filter1318, the dose order record listing 1312 may be populated with dosesthat are undergoing verification.

In turn, upon selection of a dose being verified by another user, averification control dialog box 1354 may be displayed to the user asshown in FIG. 19A. The verification control dialog box 1354 may displayto a user an indication of the other user who currently has control of(i.e., is verifying) the dose. The verification control dialog box 1354may in turn include a number of controls (e.g., buttons) that providefor actions to be taken with respect to the dose being verified. Forexample, a user may select to leave the dose in the control of the otheruser by selection of the “leave alone” button. The user may also viewdetails of the dose by selecting the “view dose” button. Finally theuser may modify the control over the dose. In an embodiment, a controlmay be provided that allows a user to revoke the control over the dosefrom another user. Furthermore, as shown in FIG. 19A, a user may takecontrol of the dose being verified by the other user by selecting the“take control” button.

Upon selection of the “take control” button, a user may obtain controlover the verification of the dose from the other user. In turn, a doseverification screen 1360 for the user to control the dose may be shownas depicted in FIG. 19B. Specifically, a dose control indicator 1356 mayprovide an indication that indicates the user has taken control over theverification of the dose. Selection of the dose control indicator 1356may provide details regarding the user and an expiration timecorresponding to the time at which the user's control over the dose maycease in a dose control information window 1358. Correspondingly, a doseverification screen 1360 of the other user may be updated such that thedose control indicator 1356 of the other users modified to indicate theuser no longer controls the verification of the dose. Furthermore, thedose control information window 1358 may be updated to display to theother user name user who is currently controlling the dose.

After doses are prepared, the resulting physical dose may be trackedduring the dose sorting and distribution 460 as shown in FIG. 4. Thatis, once the dose corresponding to the dose order is prepared, theresulting dose may be labeled, preferably at the dose preparationstation so that the label is in close proximity to the prepared dose (asopposed to the conventional practice of centralized printing of all ofthe labels for dose-orders that enter the pharmacy. The associationbetween the dose, the dose order, and the dose order record may be aresult of linking the interrogation of a scannable element to the doseorder record. A code supported by or secured to the dose itself and acode associated with a bin at the dosage form's current location canboth be interrogated and then that information uploaded to a database toprovide information regarding the whereabouts of the dose within thepharmacy. For example, the codes can be bar codes and can be sensedusing a reader such as, for example, a bar code scanner. The particularscanner or reader used and the manner of scanning can be varied withinthe context of the invention to suit the requirements of a givenimplementation. Thus, for example, the code can be an opticallyscannable bar code or an interrogatable code such as an RFID tag that issupported in lieu of or in addition to bar codes, plain text, or othercodes. The terms scanner, scanning, and scannable and/or reader,reading, or readable are intended to include wireless interrogation orpassive data reception whether they are based on an optical read, aradio frequency interrogation or an interrogation in some otherfrequency band, or a form of passive wireless data reception. Moregenerally, the codes in scannable or readable form are referred to as“tags.” As the dose progresses through the process of preparing thedose, the dose and/or additional tags associated with various locationsor processes can be scanned to track the dose through the preparationprocess. The process of scanning a tag associated with the dose tochange the dose's status and/or location information may be referred toas a scan event. Some scan events may also be triggered scan events thatfunction to change the status of the dose in the preparation process inresponse to a scan. For example, when the technician selects a dose toprepare, a dose label may be printed for the dose. The printed doselabel may have a tag associated with the dose order. Scanning the doseorder tag on the label may be a precursor in the protocol to initiatethe preparation of the dose and my simultaneously trigger the status ofthe dose to change from, for example, “pending” to “in process.”

The workflow process described herein may include a “kitting” functionthat organizes work into appropriate kits, prints picking documents toassist the technician in locating and securing the appropriate drugs andsupplies. Bar codes or the like can be used to verify the selected drugsand the workflow process includes issuing a kit report that tracks thework into and through the IV room or other room.

Additionally, scanning of tags associated with a dose may allow aplurality of dose orders may be aggregated to define a transportcollection. For example, a transport collection may be identified for aspecific final destination within a facility for more efficienttransport of doses to the final destination in the facility. As such,the final destination may, but is not required to, correspond to aphysical location within a hospital or other care facility. In thisregard, verified doses may be scanned to identify the dose order for thedose. Subsequently, a transport collection (e.g., a tag or other machinereadable identifier) may be scanned to associate the dose order with thetransport collection. In this regard, when the transport collectionundergoes a scan event (e.g., corresponding to a change in location oftransport collection), all dose order records that are associated withtransport collection may be updated without requiring each dose orderrecord and transport collection to be scanned.

The transport collections may be associated with the final destination.In this regard, prior to association of a dose order with transportcollection, one or more portions of dose metadata may be scrutinizeddetermine the appropriateness of the dose order being added to thetransport collection. For example, a transport collection may beestablished that is to be distributed to a predetermined location withina hospital. As an example, a transport collection may be definedcorresponding to a fourth floor nursing station. In this regard, if thedose order record has dose metadata associated with a corresponding doseorder record data field that indicates the dose order is not to betransported to the fourth floor nursing station, a transport collectionrule may prevent association of the dose order with the transportcollection rule. In this regard, the rule may scrutinize dose ordermetadata associated with a dose order to determine the appropriatenessof the dose order records in relation to the transport collection. Assuch, a dose order record that includes dose order metadata notassociated with acceptable metadata for the dose order record may bedisallowed from being associated with the transport collection. Themetadata scrutinized by the transport collection rule may be anyappropriate portion of metadata and not simply limited to a locationprovided in the dose order data. For example, it may be recognized thata location may be unacceptable for handle hazardous doses such aschemotherapy doses or the like. In this regard, any portion of doseorder metadata regarding the dose order (e.g., drug identifiers like)may be utilized to define transport collection rules.

In connection with the tracking of the dose in the pharmacy, thepharmacy workflow management application 114 is further capable ofresponding to any status inquiries concerning a given dose order withorder status (e.g., “unprocessed,” “in-progress at {selectedworkstation},” “processed” and the like) and optionally a location(e.g., in bin A, on cart B, in pediatric ward, etc.). The pharmacyworkflow management application 114 is also capable of monitoring andtracking the prepared dose through to its delivery with additionalstatus information (e.g., dispensation to patient {X}), as discussedwith reference to FIG. 21.

Other scan events may modify the status of a dose order record inresponse to a scan associated with a dose order record, where the scanis at least partially in connection with the dose preparation stepassociated with an independent pharmacy workflow operation to prepare adose associated with the dose order record. That is, for example, when atechnician or other user scanned the dose for a purpose associated withthe preparation of the dose, other than a specific change in the statusof the dose, the status the dose may also be modified in response to theindependent preparation step. Accordingly, as shown in FIG. 50, scanevent 5000 may be defined. The scan event may have a scan eventabbreviation 5002 and a description 5004. In the event a specificbarcode for scanning in association with the scan event 5000 isprovided, the barcode may be provided as a description 5006.Additionally, a validation rule 5008 may be applied whereby scan eventsmay only be applied certain types of doses. In the event the dose doesnot comply with the validation rule 5008, the validation rule errormessage 5010 may be provided. Furthermore, the status from which thetrigger event changes the dose 5012 as well as the status to which thetrigger event changes the dose 5014 may provided. In this regard, a scanevent may be defined by its association with a scan of a dose orderrecord or other information in relation to the preparation of the dosefor purposes other than modifying the status of the dose. However, thedose status may also be updated at any time.

In FIG. 21 a process flow is illustrated that commences when aworkstation identifies a particular dose as having been completed, asindicated at terminator 800. The local database is updated withcompletion information at step 805, and this provides status informationthat can be referenced by persons outside of the pharmacy in response toa status inquiry and by the system in managing the distribution ofsubsequent dose orders. The identification preferably associates aunique identifier with the dose. The database record associated with theidentified dose can be marked as completed. Alternatively, various othersubsystems can be notified of the completion of the dose. For example, astorage subsystem that tracks medication that is “on-hand” can beupdated with the prepared dose's record. Additionally, a deliverysubsystem can be notified that the prepared dose is completed and readyfor delivery to its destination. At a later time, for instance,according to a schedule, the information in the local database can beuploaded to a central server 390 that can be configured to communicatewith the respective local databases of multiple pharmacy systems.

With continued reference to FIG. 21, in step 830, if the pharmacistapproves the dose order, then the dose order is released in step 840 asdescribed above. On the other hand, if at step 830 the pharmacist doesnot approve the dose order based on the information presented to thepharmacist, then the dose order is rejected and the original order isadded back the dose order queue at step 850 for preparation anew. Atstep 860, the local database and the situation board are updated toreflect whether the dose order was released or not. At a later time, thelocal database can communicate the completed dose information includingany dose-approvals and dose-rejections from the local server 330 to thecentral server 390.

As may be appreciated, dose tracking takes a number of forms. Thesituation board 400 provides one manner of dose tracking because itmaintains a high level view of the work being performed in the pharmacyand because is configured to immediately instruct an observer regardingany incomplete work. Moreover, color coding or other formatting on thesituation board can immediately identify the volume of work pendingpreparation, under preparation, or prepared but not yet checked out by apharmacist (i.e., orders not yet approved for release). Such formattingmay be based on a user profile associated with user authenticationinformation used access the situation board 400. For example, withfurther reference to FIG. 47, a situation board 400 is depicted that,when accessed with a given user profile, may be displayed in the form ofsituation board 400′, which may include color coding, alternative textpresentations, or other formatted styles in relation to the datapresented on the situation board 400. Furthermore, as depicted in FIG.48, different sorting configurations such as a default sorting 4800(e.g., where dose order records are sorted by priority for dose orderpage types, patient name for patient types, and expiration time/date forproduct page types), a sorting based on elapsed time in descending order4802, or a sorting based on elapsed time and hastening order 4804 may beapplied to the dose order records displayed in the situation board 400.In any regard, the appearance of the situation board 400 may becontrolled by a style defined by a user profile. In turn, modificationsto the style associated with the user profile may allow any of theforegoing or other changes to be easily made to the situation board 400to customize the situation board 400 to a given installations need.

Dose tracking is also provided at each step in the dose preparationprocess, including without limitation, the selection and preparation ofthe ingredients, pharmacist checking, removal from the IV room fordelivery to a patient, and the actual delivery of the dose to the floor.Each of these steps is part of the workflow process that is tracked inthe system managed by the server 330. As well, there is a dose queryfunction that permits any authorized user to probe the database todiscover the current status of any particular dose or group of doses.Also, the situation board maintains alarms for doses that are due andalso tracks doses whose preparation must be delayed because of limitedstability in solution.

While the invention has been illustrated and described in detail in thedrawings and foregoing description, such illustration and description isto be considered as exemplary and not restrictive in character. Forexample, certain embodiments described hereinabove may be combinablewith other described embodiments and/or arranged in other ways (e.g.,process elements may be performed in other sequences). Accordingly, itshould be understood that only the preferred embodiment and variantsthereof have been shown and described and that all changes andmodifications that come within the spirit of the invention are desiredto be protected.

What is claimed is:
 1. A system for pharmacy workspace queue managementin a pharmacy workflow management application, comprising: a serveroperating the pharmacy workflow management application; an accessterminal remote from and in operative communication with the pharmacyworkflow management application, wherein said pharmacy workflowmanagement application is operable to access a plurality of dose orderrecords corresponding to dose orders received at said server in responseto a request for said plurality of dose order records received from theaccess terminal; and a user interface provided at said access terminalfor displaying said plurality of dose order records received from thepharmacy workflow management application, wherein said server isoperable to receive, from said access terminal, user authenticationinformation corresponding to a given user of said access terminal,wherein said pharmacy workflow management application is operable toassociate, at said server, said user authentication information with aprofile for said given user, the profile being associated with apre-defined default layout having user interface elements that aredefined at least partially based on said profile of said given user, andwherein said pharmacy workflow management application causes said userinterface to display said plurality of dose order records in thepre-defined default layout that is defined at least partially based onsaid profile of said given user.
 2. The system of claim 1, wherein saidplurality of dose order records includes at least a first dose orderrecord corresponding to a first dose order that has not been preparedand at least a second dose order record corresponding to a second doseorder that has been prepared and has not yet been verified by apharmacist.
 3. The system of claim 2, wherein said user interface isoperable to display a plurality of pages, wherein a first page of saidplurality of pages is associated with managing dose orders having await/hold status, a second page of said plurality of pages is associatedwith managing dose orders having an inline dose status, and a third pageof said plurality of pages is associated with a pharmacist workspacequeue management function.
 4. The system of claim 3, wherein saidpharmacist workspace queue management function is selected from thegroup consisting of: managing dose order on STAT dose, managing doseorder on final/STAT dose, and managing dose order being verified.
 5. Thesystem of claim 1, wherein said user interface is operable to display aplurality of collapsible areas.
 6. The system of claim 5, wherein saidplurality of collapsible areas includes a plurality of data attributesof at least one of said plurality of dose order records, and whereinsaid plurality of collapsible areas is associated with at least one of aplurality of informational groups, and wherein said data attributes arearranged with at least one of said plurality of collapsible areas atleast partially based on an association between said data attributes andat least one of said plurality of informational groups, and wherein saidplurality of informational groups is selected from the group consistingof: dose information, patient information, clinical information,formulary information, and documentation information.
 7. The system ofclaim 5, wherein said plurality of collapsible areas is configured tohide information when collapsed, and wherein said configuration of saidplurality of collapsible areas is associated with said profile of saidgiven user.
 8. The system of claim 7, wherein said user interface isconfigured to display said plurality of collapsible areas in accordancewith said profile such that the profile indicates which of thecollapsible areas are operable to hide information upon said givenuser's initial login.
 9. The system of claim 2, wherein said userinterface is configured to display numerical values of said plurality ofdose order records according to an Institute for Safe Medical Practice(“ISMP”) standard format, and wherein said user interface is configuredto receive a user input in a first format and is further configured tomodify the first format to conform to the ISMP standard format when thefirst format mismatches the ISMP standard format.
 10. The system ofclaim 2, wherein said user interface is configured to display a printview of at least one of said plurality of dose order records.
 11. Thesystem of claim 10, wherein said print view includes detailed doseinformation and product information, and wherein one collapsible area ofa plurality of collapsible areas corresponds to a collapsible materialproperties field that is adapted for user input to define a materialname.
 12. The system of claim 2, wherein said pharmacy workflowmanagement application is operable to enable modification of at leastone of said plurality of dose order records, displayable at said userinterface, wherein said modification comprises dragging an externaldocument, at said user interface, to a document input page of said userinterface such that said external document is provided as an attachmentto at least one of said plurality of dose order records and theattachment is associatively displayed along with the at least one ofsaid plurality of dose order records.
 13. The system of claim 2, whereinsaid plurality of dose order records comprises a plurality of externaldocument attachments, and wherein said user interface is configurable todisplay said external document attachments for at least one of saidplurality of dose order records, and wherein each of the plurality ofexternal document attachments is included in a listing that indicateseach of the plurality of external document attachments is associatedwith a respective dose order record.
 14. The system of claim 2, whereinsaid plurality of dose order records is associable with a data table ofsaid user interface, and wherein said plurality of dose order recordscomprises a plurality of characteristics, and wherein said pharmacyworkflow management application is operable to modify at least one ofsaid dose order records.
 15. The system of claim 14, wherein said userinterface is configurable to display, for each of said plurality of doseorder records, dose history, product history, and scan event data. 16.The system of claim 15, wherein each of said plurality of dose orderrecords is stored in corresponding relation to one or more dose orderrecord data fields populated with dose order metadata regarding eachdose order record, and wherein at least one dose order record data fieldcorresponds to a dose order status indication of said at least one doseorder record in relation to a dose preparation step of said at least onedose order record, and wherein said scan event data is at leastpartially based on said dose order status metadata.
 17. A system for usein communicating information pertaining to a pharmacy workspace queue ina pharmacy workflow management application, comprising: an accessterminal remote from and in operative communication with the pharmacyworkflow management application operated by a server, wherein saidpharmacy workflow management application is operable to access aplurality of dose order records corresponding to dose orders received atsaid server in response to a request for said plurality of dose orderrecords by a given user via the access terminal; and a user interfaceprovided at the remote access terminal for displaying said plurality ofdose order records to said given user at said user interface such that afirst dose order record and a second dose order record each appear in atleast one distinct module of a common dashboard, wherein said dashboardis comprised of a plurality of modules configurable to communicate astatus of at least one of said plurality of dose orders in said pharmacyworkspace queue to said given user, and wherein said configuration is atleast partially based on a profile for said given user, and wherein saidserver is operable to receive, from said access terminal, userauthentication information corresponding to said given user of saidaccess terminal, wherein said pharmacy workflow management applicationis operable to associate, at said server, said user authenticationinformation with the profile for said given user, the profile beingassociated with the configuration of the plurality of said modules forcommunicating the status of at least one of said plurality of doseorders in said pharmacy workspace queue, and wherein said pharmacyworkflow management application causes said user interface to displaythe plurality of said modules to communicate the status of at least oneof said plurality of dose orders in said pharmacy workspace queue. 18.The system of claim 17, wherein said plurality of dose order recordsincludes at least a first dose order record corresponding to a firstdose order that has not been prepared and at least a second dose orderrecord corresponding to second dose order that has been prepared and hasnot yet been verified by a pharmacist.
 19. The system of claim 18,wherein said configuration of said modules are is associated with amodule profile, and wherein said pharmacy workflow managementapplication is operable to associate said profile with said moduleprofile, and wherein the user interface is operable to display saidplurality of modules in accordance with said module profile.
 20. Thesystem of claim 19, wherein said module profile includes alphanumericalcustomization preferences, wherein said alphanumerical customizationpreferences include a color preference, a font preference, a sizepreference, and a text effects preference.
 21. The system of claim 18,wherein said pharmacy workflow management application is operable tosort said plurality of dose orders of said at least one module at leastpartially based on a plurality of sorting criterion, wherein a firstsorting criterion of the plurality of sorting criterion includes a dosepriority, a second sorting criterion of the plurality of sortingcriterion includes a patient name, and a third sorting criterion of theplurality of sorting criterion includes at least one of an expirationdate and an expiration time.
 22. The system of claim 21, wherein saidsorting comprises sorting said plurality of dose orders of said at leastone module at least partially based on sorting criteria in ascending ordescending order.
 23. The system of claim 19, wherein said each of saidplurality of dose order records is associated with a durationalindicator that indicates a length of time elapsed since a milestoneevent, wherein said milestone event represents a change of status of atleast one of said plurality of dose order records.
 24. The system ofclaim 23, wherein said change of status corresponds to identifyingmodified dose order metadata regarding at least one of said plurality ofdose order records, wherein said modified dose order metadata ismodified with respect to corresponding portions of dose order metadataat least partially obtained in response to an input received from saiduser.
 25. The system of claim 18, wherein said configuration is at leastpartially based on a cascading style sheet declaration contained withina single file and defined by the profile.